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SUVMARY
1. Experiments were undertaken in order to assess the use of isolated 
rat hepatocytes as a tool in drug metabolism studies. To this end the rate
of N-demethylation of ethylmoiphine and hydroxylation of biphenyl, thiabendazol 
and benzo(a)pyrene were followed using isolated hepatocytes, liver slices and 
microsomal preparations. Also conjugation reactions were followed in the 
hepatocytes.
2. With ethyimorphine N-methylation and benzo(a)pyrene hydroxylation 
highest enzyme activities were observed in the microsomal preparations with 
slices showing more activity than did the hepatocytes. For biphenyl, however, 
the highest rates of hydroxylation were observed in hepatocytes. Isolated 
cells were shown to be capable of performing phase II reactions with the 
hydroxylated metabolites of biphenyl. This was characteristic of cells 
capable of excluding trypan blue (viable cells). Non-viable cells, produced 
by exposure to high biphenyl concentrations, although capable of phase I 
reactions were unable to conjugate the hydroxylated products.
3. As described by other workers, it was thought possible that the low 
enzyme activities observed in isolated hepatocytes could be due to leakage of 
one or more of the NADPH regenerating cofactors from the cells into the medium.
In order to test this hypothesis a number of experiments were conducted in 
which CO factors were added to the hepatocytes incubation medium in an attempt 
to prevent such leakage.
4. It was shown that addition of NADPH and glucose 6-phosphate (independently 
and together) to the hepatocyte incubation medium greatly enhanced the hydroxy­
lation of biphenyl hydroxylation and ethyimorphine N-demethylation, to levels
in great excess of those found in microsomal preparations. Addition of glucose
6-phosphate dehydrogenase had no detectable effect. The results obtained 
from this study were very variable. It is suggested that this variation 
is the result of varying degrees of damage to the cell membrane. The concept 
of a cell being classed as being either non-viable or viable as a result of 
the dye exclusion test is too 'black and white'. The membrane probably 
undergoes a spectrum of changes, with the uptake of ^ e  monitoring only 
a small change somewhere on this spectrum.
5. Experiments using radio-labelled substrates indicated that NADPH
and glucose 6-phosphate were actively taken iç) from the medium fay hepatocytes. 
It was also demonstrated that glucose 6-phosphate was taken ip from a perfusion 
medium by an isolated perfused rat liver, although this was only very slight.
It is possible that glucose 6-phosphate is only taken up by damaged cells, 
such as those produced during the isolation procedures. If this is the case, 
the controversy over whether or not benefit is gained by use of glucose 
6-phosphate during post surgical shock to aid recoveiy may be resolved.
6. It is concluded that isolated rat hepatocytes used in the presence 
of glucose 6-phosphate is a useful tool in drug metabolism studies, for
not only does it give higher rates of metabolism than microsomal preparations, 
but it is also capable of monitoring phase II reactions.
Praise be to Allah, the Teacher, the Unique, Majesty 
of the Heavens, the Exalted, the Glorious. Glory be to 
Him, the Eternal Being who drew forth creatures from 
Nothingness. He floods our minds with light to the point 
of having revealed to them that which was hidden. In His 
goodness. He created man and gave him judgment and 
speech as privileges. He allowed him access to knowledge 
through the perceptions of his senses and, through reason­
ing, opened to him the invisible world. The mind of man 
is bound to a living soul of which the existence is proved 
beyond all doubt. Allah distributed judgment and senses 
among all men at the same time as life. But each one has 
his own character and in that His Marvellous Wisdom 
shines forth. Thus, whoever has banished Ugliness from 
his soul has been able to acquire Virtue. The arts and 
speech distinguish man from animal. The best of men do 
good by accompanying it with courteous words, preoccupy­
ing themselves with the body, granting to it its rightful 
mirth. ,
Avicenna
:,^J
. X . . / ,. L x' . . %
iSj^  oi/
The sons of Adam are limbs of each other 
Having been created of one essence.
When the calamity of time afflicts one limb 
The other limbs cannot remain at rest.
If thou hast no sympathy for the troubles of others 
Thou art unworthy to be called by the name of a man.
The Gidistan o f  Sa^di
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CHAPTER I
GENERAL INTRODUCTION
GENERAL INTRODUCTION
Xenobiotics;
Animais are exposed to these materials, contained 
in their foods, in food additives, pesticides, drugs and 
industrial chemicals. These compounds which do not belong 
to the body and which are used to treat the body are 
known as xenobiotics. The terminology of xenobiotic is 
derived from the Greek language (xeno = foreign, strange ; 
biotic = relating to life). These compounds are foreign 
to the normal metabolic pathways and if they remain in the 
body, may affect the normal processes of metabolism either 
producing changes or poisoning which may result in death.
Because the body is similar to a machine, it requires 
energy. Animals obtain their energy from the metabolism of 
nutrients but generally are unable to do so from these 
foreign compounds (Xenobiotics). A number of enzymes are 
naturally present in the body, to neutralize any 
pharmacological activity which these compounds may possess 
and also to eliminate them from the body. These reactions 
are known as detoxication reactions and the most important 
organ for these enzymes is the liver.
Metabolism of Xenobiotics.
Brodie (1^64) has stated that if there were no 
such process as dru^ metabolism, it would take the body 
about a hundred years to terminate the action of such 
drug's as pentobarbital, which is lipid-soluble and thus 
can not be readily excreted without being metabolized.
By 1 9 0 0 most of the major routes by which foreign 
compounds undergo biotransformation (Fig. l.l) and 
conjugation (Fig. 1,2) were known.
OH
metaholie 
transform­
ation
conjug­
ation
OC.H^Og
Benzene Phenol Phenyl-
glucuronide
OSO H
Phenyl-
sulphate
(Fis. 1.1)
If a compound has already a functional group it might 
undergo only phase II reactions (Parke I9 6 8 ),
GOGH
Benzoic
acid
conjug 
ation 
(major)
\
\
CO.NHCH^COOH
Benzoylglycine 
(Hippuric acid)
metabolic 
transf orm- 
ation 
(minor) \
Hydroxybenzoic
acid
CO.CgH^Og
Benzoylglucuronide
Hydroxybenzoic
conjugation acid conjugation
(Fig. 1.2)
Since then, especially in the past 25 years, the field 
has continued to (^ row althoUj^h it was only comparatively 
recently that vjorkers realised the importance of 
understanding the metabolism of toxic compounds such as 
pesticides, herbicides, fungicides, cosmetics and food 
additive s.
The mammalian me tabo!^ism of a drug increases the 
polarity of the molecule making it less lipophilic 
(lipid-soluble) and more hydrophilic (water-soluble). 
Those hydrophilic derivatives are then eliminated from 
the body either as a constituent of the bile or of the 
urine, A sim%jle typical example is the detoxication of 
alcohols by metabolism into different compounds as 
follows (Smith 1 9 6 9 )»
R.CIIO -»-R-COOH ----- KCOg+ H^o
R-CO.O.C^H^O^
• ° 6 V 6
and also (Table l.l).
But we cannot generalise that loss of activity 
occurs with all xenobiotics. Some of them become more 
active and this activation might increase the toxicity 
(intoxication),
1, An inactive substrate may be called a prodrug. The 
prodrug has no effect vitro. but dni vivo it is changed
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into an effective compound, e.g. prontosil. In 1937 
Domagk found that prontosil when fed to mice, was able 
to protect them against a lethal infection of streptococcus. 
However it was completely inactive in destroying 
streptococci in vitro « It was later found that in the 
body pronto sil undergoes reduction, yielding sulphanilamide, 
which is the active drug.
NH
SO
NH,
NH
NH
+
NH
Prontosil Sulphanilamide
2. An inactive compound can be converted into a toxic 
compound, This procedure is called lethal synthesis 
(Peters 1932) e.g. fluoroc\cetic acid. This compound has 
little pliarmacological activity. However, after metabolism 
it is converted into fluorocitrie acid which, being an 
analogue of citric acid, inliibits the enzyme which 
dehydrates citric acid into cis-aconitic acid. It 
therefore inhibits one of the most important enzymes 
of the Kreb*s cycle.
3, It is also possible for an active drug to be changed 
into another. The metabolic product may have similar or 
different pharmacological actions to the parent (drug). 
Some examples of such; cases are in (Table 1.2),
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Drug Metabolism Patliways
Drugs can undergo two types of reaction, Imown as 
phase I and phase II reactions. The phase I reactions 
are metabolic transformations and phase II reactions are 
conjugations with other molecules. A drug may be 
metabolized by either one or both tyjDes of these reactions
k '(Parke I9 6 8 ).
A. Phase I
Different reactions and enzyme localization.
Phase I reactions are principally catalysed by 
enzyme systems of the endoplasmic reticulum (microsomal 
enzymes) of various tissues and organs, but mostly of the 
liver. However, non-microsomal onzyme reactions are also 
involved in these metabolic transformations, e.g. 
aromatization of cyclohexane carboxylie acid to benzoic 
acid. The gut microflora have also been shown to play an 
important role in the metabolism of foreign compound.
As already stated, phase I reactions can occur in 
several.tissues and organs, some occurring in the 
gastrointestinal tract, others in the lung, the thyroid 
gland, the testes, the kidneys, the skin and the placenta 
have also been implicated.
The micro somal enzyme systems are involved in 
oxidation, reduction and hydrolysis reactions (table 1,3).
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The micro somal fraction ( Prepsir ation Page 4-3) of
liver cells is derived from the endoplasmic reticulum,
a net-work of submicroscopic tubules that is present in
cytoplasm of most animal cells. There are two forms :
tlie rough endoplasmic reticulum is studded with ribosomes,
protein
(small granules of RNA& that translate the genetic code into 
the sequence of amino acids which constitute proteins 
(Kappas & Alvares 1975) and the smooth endoplasmic reticulum whic 
is 1V0.U tl;ear pai-tith/s ( Pa lade and Sceküitz 1956) , In the 
liver both kintls of endo%)lasmic reticulum transform foreign 
substances by complex enzyme systems, but the smooth 
endoplasmic reticulun: has the highest enzyme activities
(llol tznian e_t aj[^. i9 6 0 ; Gram, Rogers & Fonts I9 6 7 ) . Ernster
& (fjerenius? (1 9 6 5 ) have I'eported that the enzymes are formed 
i n  the rough endoplasmic reticulum but when this becomes 
saturated with enzymes the ribosomes are lost resulting 
in smooth endoplasmic reticulum, (hepatic microsomal 
fraction is obi;ained from the endoplasmic reticulum by 
using differential centrifugation of the tissue homogenate.)
It is unlikely tiiat tiie endoplasmic reticulum can be 
separated from cells as cin intact structure. If liver 
cells are homogenized and then centrifuged, the tubular 
reticulum fractures and fragments of membrane are sealed 
off to form the tiny vesicles, or sacs named microsomes 
(Pouts 1 9 6 1 ; Dallner I9 6 3 ),
The micro somal frac tion thus obtained from liver cells 
became a natux'al source of enzymes for laboratory studies 
of liver cell metabolism (Mueller and Miller 1949, 1955)*
10
This system was later used extensively to study the metabolism 
of steroids (Kaufman 1957» Kuntzman et al « 1964), lipids 
(Preiss & Block 1964), cind foreign organic compounds 
(Gillette ejt aT. I9 6 9 ) such as the hydroxylation of a 
large number of lipid-soluble substrates which require 
the presence of NADPH and 0^ (Brodie et al. 195^). This 
enzyme system has been called "mixed function bxidase'* by 
Mason (1 9 6 5 ) and "monooxygenase" by Hayaishi (I9 6 9 )«
Microsomal Enzyme systems.
a. Monooxygenase or Mixed Function Oxidase:
This reaction may be generalized as follows:
1. NADPH + H*^  + A--------- ► AH + NADP*^
2 , AH,^  + 0  ^ — ----------- > "active oxygen"
3» "active oxygen" + substrate------ v oxidized form + A + H^O
NADPH + Oo + substrate NADP^ + H^O + oxidized form
(Gillette I9 6 2 , I9 6 3 )
According to the mixed-function oxidase mechanism,
NADPH reduces a component (a ) present in the microsomes 
which reacts with "activated oxygen" to yield an 
intermediate. The "activated oxygen" is then transferred 
to drug substrate.
This mechanism shows that equivalent amounts of 
NADPH, oxygen and substrate are needed in the reaction, 
a s toictiime trie re lationsiiip which has been obtained for 
the hydroxylation of steroids (Kuntzman ejk ai. 1964), the 
peroxidation of lipids (Ürreniun, Dallner & Ernster 1964 ; 
Hogberg, Orrenius & O ’Brien 1975; Hogberg e_t ai 1975) and 
benzo (a )pyrene hydroxylation (Conney I9 6 7 ).
11
b * He patte reductase
Micj’osomal drug metabolisrii is not limited to oxidative 
reac tions. As Trefoiiel aJ_. ( 1935 ) found %)rontosil is 
metabolized by reduction to produce sulfanilamide• Many 
azo dyes, such, as dimetliylaminoazobenzei'B, undergo 
reduction reactions ( Stevenson, Dobriner & Rhoads 194.2) • 
p-Nitrobenzoic acid undergoes nitro reduction. These 
reactions occur in the hepatic micro social fraction which 
contains NADPH-dependent enzymes (Mueller & Miller 1950)• 
Kajnni & Gillette (1 9 6 3 a) found that highly purified 
preparations of porcine liver NADPlI-cytochrome reductase, 
could also reduce azo compounds. It is clear that 
micro somal NADPH-cytochrome reductase catalyses the 
reduction of a%o compounds as well cis the reduction of FAD 
(flavin adenine dinuc leo tide ) ( Kaimn 6 Gillette 1 9 6 3 b) .
Parke (I9 6 8 ) has put forward the following mechanisms 
f o r t} j e e d 11 c t i. o n :
NADPH^-cyt.C
NADPH^ + FAD reductase FADH^ + NADP
3FADH,, + RNOg _________________ ^ 3FAD + RNH^ + 2HpO
Ni tro reductase is only possible under anaerobic conditions. 
Gillette et al, (I9 6 8 ) employed p-nitrobenzoic acid as a 
substrate and found the reduction was mediated by 
cytochrome P-450. It was realised that cytochrome P-450 
not only participates in nit1 0 reduction but also is involved 
in azo reduc tion. Gille t te (I9 6 6 ) suggested that there were 
two pathways of azo reduction in liver microsomes, one through 
NADPH-cytochrome reductase and the second azo reductase path— 
way tiirough cytochrome P~450. An electron transport system 
was' proposed that can explain both, either the oxidative
12
or the reciLictive pathway of microsomal drug metabolism system 
scliematically ( Fig. 1.3).
Flavins
NADPH-
NADPi
NADH
NAD
Azo
-Oxidxc >Red
Cyt c Y 7
Reduct A
S w R e d X ^ Oxid
Reduced
Products Substrates
Oxid
Oxid
Hydroxylated
Substrates
Reduced
Product
P-4 5 O-CO
Flavins Nitro 
Azo Azo
Reduced
Product
Fig. (1 .3 )
Another type of reduction is reductive dehalogenation,
Cytochrome P-430 and microsomal drug metabolism.
Cytochrome P-430 was originally referred to as the binding 
pigimmt (iClingenberg 1958» Garfinkel 1958 eind Omura & Sato 
1 9 6 2 , \()6k ^ 1964a) but wiien tlie pigment was shown to be a
iiaemoprotein the name was changed to "cytochrome P--430’j, 
because of the characteristic absorption maximum 
at 4 5 0 nm of the CO ligand complex of the reduced cytochrome.
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The highest content of cytochname P-450 has been found in the 
liver, much smaller amounts occur in kidney (Ellin et 1 9 7 3 ^
lung (Uehleke (1 9 6 8 ) intestinal mucosa (Lehrmann,
Ullrich & Rurnmel 1973) skin (Alvares ^t ^1 1973)
i.e. kidney contains one seventh of the concentration of 
cytochrome P-450 of liver tissue, and other tissues contain 
even less. The presence of c y tochrome P-d(50; has als'oe been‘«repcartod 
in mitochondria from the corpus luteum (Yohro & Horie I9 6 7 ) 
and in adrenocortical mitochondria (Jefcoate & Boyd 1971)#
This haemoprotein has been found in liver microsomes from 
a variety of verterbrates including several mammals such as 
man (Alvares, ejk aT 1 9 6 9 )» mice (Davies, Gigon & Gillette 
1 9 6 9 ); guinea pigs (Kupfer & Orreniors 1970), rats (Schenkraan, 
Reiminer & Estabrook I9 6 7 ) » rabbits (Omura & Sato 19^4) , and 
non-mammals such as birds (Mitani ejb aT 1971)» snakes, frogs 
and fishes (Buhler & Rasmussen I9 6 8 ). Non-vertebrates, such 
as insects (Pukami e_t al. I9 6 9 ) especially house flies 
(Capdevila ejfc aT. 19735 Tate, Plapp & Hodgson 1973) higher 
plants (Markham, Hartman & Parke 1972; McFarlane ejb al 1975) 
yeast ( Ishidate, Kawaguchi & Tagama I9 6 9 ; Tshidate et al 19^9 ; 
Wiseman, Gondal 6 Simp 1975) bacteria (Appleby I9 6 7 , 19^8,
1 9 6 9 , and Katagire et al I9 6 8 ) also contain cytochrome P-450,
A soluble pure crystalline form of this haemoprotein has been 
obtained from pseudomonas putida (Yu & Gunsalus 1970, Yu ejt al 
1 9 7 4 , Griffin et ^  1975).
However, changes in mixed function oxidase activity 
have frequently been correlated with changes in cyt@chrci^5P-450 
content, but there are many instances in which the activity 
is not directly proportional to P-450 content (Kratz and 
Standinger I9 6 7 ; Degkwitz e_t I9 6 8 ) , For example,
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Davies ejb aX (1 9 6 9) found that species variations in 
ethylmorphine N-demethylation were nearly paralleled by 
differences in the rate of cytochrome P-450 reduction and 
not by differences in cytochrome P-450 content or 
NADPH-cytochrome C reductase activity. These findings 
thus raised the possibility that the rate-limiting step 
of ethylmorphine N-demethylation might be the rate of 
reduction of cytochrome P-450 by cytochrome P-450 reductase. 
Since the discovery of this haemoprotein many papers have 
been published concerning its various properties and 
three different types of electron transport systems in 
which cytochrome P-4^0 functions have been found and are 
classified by Estabrook as follows:
General classes of cytochrome P-450 catalyzed reactions 
(Estabrook e_t aX 1972)
I. Liver Microsomes
12 membrane bound cytochromes P-430 
3 membrane bound cytochromes b^
1 membrane bound flavoprotein
II. Adrenal Mitochondria
1 membrane bound P-450 
1 soluble iron sulphur protein 
? soluble flavoprotein •
III. Bacterial System 
1 soluble P— 430
1 soluble iron sulphur protein 
? soluble flavoprotein
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General mechanism of hydroxylation reactions
Tile electron transpprt system of cytochrome P-4^0 which
has different sources in many respects, involves a reaction
' '
mechanism sequence in which cytochrome P-4^0 interacts with 
druc,, ox-y^en and electron donors, (Gunsalus, Tyson & 
Lipscomb, 1972; Peterson et. 1972; Schleyer, Cooper & 
Rosenthal 1972; Coon, Strubel & Boyer 1973)» Estabrook 
et al (1 9 7 3 ) have su^gpsted that the system involved 
NADPîî^ , a pho spholipid , a pro t oliaeme-sulphide protein 
complex, as cytochrome P-450, and an electron transport 
system of cytochrome P-4^0 reductase, NADPH^-cytochrome c 
reductase with a contribution from cytochrome b^.
P- 4 5 0 + + +
NADPH"X"
S
p-4sot7 w p-456
dGH NADH,
Tile electron transport complex of the endoplasmic reticulum 
is proposed as functional for cytochrome P-430 catalyzed 
reactions. The flavoprotein NaDPH cytochrome c reductase 
is indicated as fp^ , while the flavoprotein NADH-cytochrome b^ 
reductase is designated as f . An unknown electron transferp
2
component "X" is presumed to be required for reduction of 
cytociirome P-4^0 in tiie presence of NADPH, This mechanism 
reaction of cytociiroine P-4^0 with sub strate ( s ) , electrons(e) 
and oxyjen (Op) or carbon monoxide (CO) has been described 
by Estabrook (l975)«
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Mueller and Miller (1949» 1953) described the
contribution of NADH, in addition to NADPH, in drug 
metabolism. Since then it has been confirmed by Conney 
et al, (1 9 5 7 ) Nilsson & Johnson (1 9 6 3 ); and Ulrich (1 9 6 9 ). 
However, Gillette, Davies & Sasame (197%) suggested that 
NADH can serve as an electron donor for hepatic hydroxylation, 
although the rate of hydroxylation is slower. Recently 
other publications have suggested that cytochrome P-450 
can be reduced by NADH via some of the electron carriers in 
the cytochrome b^ chain (Hilderbrandt e_t aJ 1971» Hrycay & 
O'Brien 1974). West e_t aJ. (1974) found that the enzyme 
system from rat liver microsomes which catalyzes the NADPI I- 
dependent hydroxylation of benzo(a)pyrene can be 
solubilized, separated and reconstituted. It has been 
shown that the basic components of this NADH—mediated 
electron transport chain were cytochrome b^, NADH-cytOchrdme b^ 
reductase; lipid and cytochrome P-448 (cytochrome Pj-450) ,
The oxidation-reduction of cytochrome P-450 plus 
substrate has been proposed in Fig(l-^) step by step.
(1 ) A substrate (s) interacts with the low spin form of 
ferric cytochrome P-450 and the result is the (cyt, P-450^^-S) 
complex (low spin form becomes high spin form). (2) One 
electron reduces the ferric (cyt, P-450^*-S) complex to 
ferrous (cyt, P-450^*-S) complex. It was postulated that 
the electron is transported by NADPH^ cytochrome c reductase 
(fp^ , ) through unknown carrier (x) to cytochrome P-450,
Ragnotti, Lawford & Campbell (1 9 6 9 ) have studied the synthesis 
of NADPH-cytochrome c reductase a constitutive membrane 
protein, on both free and bound ribosomes* Also the presence 
of NADH^ & NADPH^ cytochrome c reductase has been demonstrated 
by Ernster and Jones (I9 6 2 ) & Packer & Rahman (1 9 6 2 ).
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This has caused a certain amount of controversy as there 
is no evidence for the presence of cytochroiiie c,
(3 ) The binding of oxygen with the latter complex to 
form an oxy-cytochrome substrate complex (this
complex when interacting with carbon monoxide (CO) 
instead of oxygen (O^) has an absorbance band at 4^0 nm - 
and was therefore called cytochrome P-450 (Oinura & Sato 
19641^, (4) The oxygenated complex of the third step
undergoes a second electron transfer which is still 
obscure (West at ad 1974)(Fig, 1,5)to form a product with 
one of the atoms of oxygen inserted in the substrate and 
the other atom goes to form water, (5 ) The unstable 
complex of cytochrome P-450- product (with the low spin 
form of ferric ion), is formed by the intermolecular 
rearrang'vinen t of the cytochrome P-450*^*- substrate -oxygen 
complex. This then breaks down to yield the product and 
the original heamoprotein (cytochrome P-450),
NADPH lipid
NADPH ______  ^ cytochrome C     ^ Cytochrome P-450__^0^
reductase or
P-448
/
\  lipid
%
NADH  ^X'
NADH  ^cytochrome b^ _________^ cytochrome b^____^ C N  ^0
reductase lipid sensitive
factor
Fig. (1.5 ).
It is accepted that liver microsomes involve two electron 
transport systems, but it is not certain by which of these 
chains NADH transfers its reducing equivalents to 
cytochrome P-450 (West ab al 1974)
1#
Comparison of oxidation reactions in mitochondria and in 
endoplasmic reticulum
The microsomal (E.R.) and mitochondrial enzyme systems 
have capacity to transport electrons to a receptor—site 
(cytochrome acceptor). The mechanisms for each system are 
given below:
, + cyt oxidase
4e + 4H + 0^ - .. ________________ p, mitochondrial
X + 2e"" + 2H*^  + Op _______________ XO + HpO endoplasmic
mixed function ^ reticulum
oxidase microsomal,
(cyt, P-4 5 0 )
Electron transfer to 0^ in mitochondria is catalyzed by 
cytochrome oxidase whilst in microsomes it is catalyzed by 
cytochrome P-450 (Ornura jet ai, I9 6 5 )
The mitochondrial cytochrome oxidase utilizes four 
electrons for reduction of one molecule of oxygen whereas 
the hepatic endoplasmic reticulum, which contains the mono­
oxygenases, consumes two electrons, one for reduction of one 
atom of oxygen to produce water, the second for the 
production of an oxygenaseted compound (XO) from a particular 
substrate ( x ) , ;
The electron transport system in the mitochondria is 
coupled with the formation of high energy bondd, in ATP,
This is not found in the endoplasmic reticulum (Page I6 ),
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Différent types of cytochromes P-450
The cytochrome P-450 associated with the endoplasmic 
reticulnrn of hepatocytes in drug metabolism may have different 
characteristics (Orrenieus d Ernster 19u4). A widespread 
study involved ?,retreatuiunt of anii.ials with various inducing 
a^ on-: a (C aune y I9 6 7 ) which has resulted in some understanding 
of the complexity or multiplicity of cytochrome P-450,
However various drugs stimulate different hydroxylation 
activities. Two explanations have been advanced, namely
Mannering (1 9 7 1 ) has reported that there is a family of
cytochrome P-450 pigments with significant differences in 
their chemic al and physical characters, or there is a single 
cy tochrome P-450 wiiich can exhibit different functional forms
(Comal & Gay 1 or 1973)* Tliesc have also been considered by
Lu e_t ad (1971); Jefcoatc, Hume & Boyd (1970).
Spec tropTiotoiiie trie studies have been carried out to 
find out the meciianism by which phénobarbital and many other 
drugs stimulate the synthesis of the microsomal enzyme system, 
and whetiier this biosynthesis could be different from the 
mochauism of induction by polycyclic hydrocarbons.
Studies (lluntzman e_t al 19^9 î Mannering ^  aJL I9 6 9 ) 
have demonstrated a small but significant alteration in the 
position of tlie absorption band maximum of the CO-complex 
of reduced cytochrome P-450 present in microsomes prepared 
from livers of animals which had been pretreated with 
polycyclic aroma tic liydrocarbon s. Therefore the term 
cy tociirome s P-448 was introduced (Alvares et al 19^7 )
Lo distinguisn it two cytochrome P— 450 • In another
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terminology cytochrome P-448 is called cytochrome P-450 
(Sladek & Mannering I9 6 6 , I9 6 9 ), P-446 (Hildabrank e_t al 
1 9 6 8 ), high spin P-450 and type a P-450 (Jefcoat & Gaylor I9 6 9 )
Further studies on the binding of cytochrome P-450 with 
substrate have been carried out using the technique of 
electron paramagnetic resonance (EPR), It was suggested 
that phénobarbital treatment of an animal enhances the 
biosynthesis of a low spin ferric heamoprotein whereas 
pretreatment of an animal with 3-methylcholanthrene 
results in the biosynthesis of a high spin ferric 
heamoprotein. On the other hand it has been reported 
that cytoclii’ome P-448 is not a stable complex of cytocJirome 
P-450 with 3-methyIcholanthrene or one of its metabolites 
( Parke 1975 ; Gray & Parke 1973) # Sehenkman e_t _al ( I9 6 9 ) 
suggested that the pigment induced upon treatment of animals 
with a polycylic hydrocarbon may be due to the formation 
in vivo of a complex of cytochrome P-450 with the inducing 
agent or a metabolite. There is the possibility that 
the cytochrome P-448 observed by the induction with 
polycylic hydrocarbons is the result of substrate 
interaction with cytochrome P-450 Jjo vivo causing the 
conversion of the low spin form to the high spin form of 
the haemoprotein.
Drugs (substrates) have been classified by different 
types of cytochrome P-450 binding spectra. The three main 
types are type I, type II and modified type II or reverse 
type I (Schenkiiian e_t ad 19^7 » Sehenkman, Wilson & Cinti 1972 ) .
It has been suggested that type I spectral changes are 
caused by the displacement of the sixth ligand from a
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liydropliobic region of the cipoenzyiiie by the substrate 
( Sciiejikitian & Sato I9 6 8 ), The absorption peak is in the 
range about 3 9 0 nm and the trough is 425 nm (Pig. 1 ,6 ),
The type II spectrum is due to a direct aminoferroproto- 
porphyrin binding of the substrate involving the sixth 
ligand of iron (Temple 1971)• The absorption peak is 
about 4 3 0 nm and a trough at 390 nm (Fig. 1,6), Modified 
type II or inverse type I (Diehl, Schadelin & Ullrich 1970) 
or reverse type I ( Sehenkman eJb al 1972) would involve 
: binding ofl thé i apoenzyrae of the mixed function
oxidase system. However type II compounds can displace 
carbon monoxide from reduced P-450, the reverse type I 
compound can not.
In spectrophotometric terminology 'reverse type I ' 
has been called "type II A" (Mailman et al 1974) and it 
has been suggested that oxygen atoms act, like nitrogen 
atoms, as nucleophiles replacing another ligand at the 
5 th or 6 th ligand position of the heem group of 
cytochrome P-450,
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Fig. (1.6)
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The different binding spectra from rat liver microsomes 
produced by various drug categories (Orrenius at 1972)
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Some Important Techniques used to Study Drug Action and
Metabolism.
Technique Example
1 . Intact animal rat
2 . Isolated perfused organ liver perfusion
3. Tissue slice liver slice
4. Isolated cells hepatocytes & 
kupfer cells
4" Cell culture parenchymal cells
5. Hornogenates liver homogenate
6 . Subcellular fraction microsomes
7. Pure enzymes (mixed function
These systems facilitate the study of the pharmacokinetics 
and metabolism of ocehobiotics.
1, Intact Animal
The intact animal (in vivo) is very important for the 
study of pharmacology.^ i theraputics, metabolic balance 
and drug metabolism. Following the fate of xénobiotics 
(foreign compounds) in the intact animal is complicated by 
systemic factors, such as tissue distribution, the effects 
of hormones, etc.
The metabolism of specific organs may be studied by 
following changes in the composition of blood constituents 
after passage through hn- organ such as catheterization of 
the hepatic portal vein and the hepatic vein.
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One of the methods used for obtaining samples of 
tissue from the organs- of intact, live animals for the 
investigation of drug metabolism is the direct sampling of 
the organ by using biopsy technique. The tissue sections 
being removed surgically by special biopsy needles under 
local anaesthetic in order to obtain viable tissue.
2, Isolated Perfused Organ.
One of the useful techniques that can be used to 
study directly the selective organ is perfusion. This 
technique is used for two purposes.
1, Perfusion of organ for the study of the metabolism of 
xenobiotics added to the perfusate, especially in the 
field of pharmacokinetics.
2. Perfusion of organ leading to the isolation of individual 
cells of the organs.
In the first process, the organ is kept for periods of 
time in a similar state to the body by pumping blood serum or 
some other perfusion liquid,together with oxygen, or sometimes 
another gas (CO^) to supplement the correct condition of 
the system, through the vascular tree under a set of carefully 
controlled conditions.
By taking samples of the fluid perfusing the organ, an 
estimate can be made of the metabolism of xénobiotics as well 
as following physiologijalpararaeters of vivo organ function 
e.g. in liver perfusion experiments it is possible to measure 
the biliary flow rate, observe the kinetics of substrate 
disappearance and metabolite formation and watch for signs of 
cell damage by following plasma enzyme levels. In kidney
perfusion experiments, urine output can be measured and i„
Off
heart perfusions the heart rate and pressure can be 
monitored.
The use of isolated organs to study drug metabolism 
has been a part of biochemical pharmacology for a long time 
and has been so commonly used that no particular person can 
claim credit for it. The first recorded information appears 
to have been made by’ Bernard in 1855 when he used liver 
perfusion and demonstrated the role of the livei' in regulating 
blood sugar. Almost fifty^ years later Brodie (1 9O3 ) and 
Gruber & Bain (I9 0 3 ) showed that the perfused or^an could 
perform metabolic functions. When Biseman was discussing 
about the paper delivered by Chapman e_t al (1 9 6 0 ) on the 
"studies in isolated organ iliy siology-; bi'omsulphalein 
cléarance in the isolated perfused bovine liver", he said 
"I would like to predict that the development of more perfect 
tecliniques of liver perfusion has real clinical importance."
Reasons why perfusion of isolated liver is a useful 
technique are as follows: (Carattini e_t al 1 9 7 3 )
a. Metabolism of xenobiotics is complex involving 
metabolism in various organs, the most significant site being 
the li'ver. In this case tliis organ can be studied separately 
without interference of the other organs,
b. The majority of metabolic biotransformations and 
conjugations occur in the liver, such as mixed function 
oxidations, reductions etc, (i^ iiase l) and glucuronidation, 
acétylation, etc, (phasell). These can be determined by
exi'>eriiiients using labelled compounds,
c. Detoxication following excretion in urine makes it 
difficult to measure drug conversion, especicilly in the
blood, because of low concentrations found. Higher blood 
levels of drugs may result in limitations because of 
pharmacodynamic and toxic effects. The perfusion technique 
overcomes these difficulties.
The apparatus for use in rat liver perfusion was 
described by Werthessen (1949),
More recent work on the metabolism of xenobiotics has 
been carried out using liver perfusion methods such as the 
pharmacokinetic measurement of imipramine and its metabolites 
formed in rat liver perfusion systems (Bickel & Borner 1974),
The process for liver perfusion to obtain separate 
cellular components is similar to that used for studying 
xenobiotic metabolism in the isolated organ, except that as 
tlie purpose is the disintegration of the tissue of the organ 
the period of perfusion (infusion) is shorter and studies are 
performed on the viable or non-viable cells, e.g. preparation 
of isolated hepatocytes by using liver perfusion (Page 44)*
3. Tissue slices
The slice technique can be used to examine the more 
detailed drug action and metabolism. Usually, large organs, 
such as liver, kidney are sliced by hand or mechanically by 
using a microtome (Page 48). The experiment is done with 
thin slices in which diffusion barriers are minimized by 
slice dimensions and where interior cells are intact but 
surface cells are damaged. Naturally some tissues are thin 
enough so that no further slicing is necessary, such as rat 
or mouse diaphragm.
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As with the technique of isolated organ perfusion, it 
is difficult to know who first used organs or tissues in 
sliced form, but the literature shows that Léloir & Münoz ' 
(1 9 3 8 ) used sliced liver for pharmacological studies (ethyl 
alcohol metabolism in animal tissue). Much recent work has 
been carried out using liver slices, such as carnitine 
synthe sis in rat tissue slices (Haigler & Broquist 1974) 
and metabolism of oestradiol and 2-hydroxy-oestradiol in 
rat liver slices (Ball, Bo:)pen & Knuppen 1974) ,
^. IsoInted Cells
One of the more recent and important techniques which 
is sometime s %)ref erred to the oi'gan perfusion technique is 
the use of isolated cells (single cell population). This 
techni<iue has been used widely for studying the metabolism 
of xenobiotics directly on the selective homogenous cell 
without the difficulty of p]"oblems in perfused liver 
(Mitzkat and Meyer 1973; fonta and Dionigi 1973)* On the 
other hand it is easier to look at the metabolism of 
xenobiotics on a special cell line rather than slices.
This method.is still closer to the in vivo state than the 
homogenate p)reparati on,
The Isolation of single cells can be followed by 
enzymic digestion of minced organs, such as the preparation 
of isolated hepatocytes by enzymic digestion of liver tissue 
mince s wit il tlie crude enzyiue collagcnase which separates the 
hepatic cells (Howard, Lee & lb sen 1073) or by the method 
of perfusion system (Berry & Friend I9 6 9 ; Seglen 197 21^ *
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Liver cells have been isolated by various methods, such 
as forcing the tissue through a stainless steel mesh screen, 
(Kaltenbacii 1954) ; by tryptic digestion (Dulbecco & 3/oget 
1 9 5 4 ); by incubation in acid solution (Longmuir & . Ap Ressil95^) * 
but few intact cells were produced. binder son ( 1 9 5 3 ) obtained 
a high yield of cells by perfusion of liver with Ca - free 
Lock’s solution containing chelating agents (such as isotonic 
sodium citrate) following subsequent dispersion. This last 
method was probably the first primary step of liver perfusion 
leading to the isolation of cells.
Most of these workers were looking for a way to obtain 
a high yield of viable cells, so they tried to design a 
specific technique. Sometimes they used a completely 
different technique, e.g. Branster & Morton (l957) developed 
a technique for the isolation of cells in high yield in 
physiological solution without the use of enzymes, chelating 
agents or abnormal pH. Recently it has been common to use 
freshly prepared single cells in various aspects of metabolism, 
especially the use of liver loaranchymal cells for the study 
of metabolism of drugs (Henderson & Dewaide I9 6 9 ), drug 
metabolism linked to cy tocjir'Vic (Mo Id eus et,al 19?4), o:cidation
of succinate (Mapes & Harris 1975)> bxidation of ethanol 
(Meijer e_t 1975) and synthesis and secretion of substances 
such as fibrinogen and albumin (Crane & Miller 1974) , bile 
acids (Anwer, Kroker & Hegner 1975)» synthesis of fatty acid 
synthetase (Craig & Porter 1973) and regulation of 
phospholipid biosynthesis (Sundler &Akesson 1975). This 
technique has also been used for investigation of the 
glycogenesis and glycogenolysis pathways such as the effect 
of insulin and acetylcholine on activation of glycogen,
synthase (Akpan, Gardner & Wagle 19?4), and of gluconepgenesis
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(Veneziale et al 1 9 7 5 )> regulation by insulin of 
gluconeogenesis (Claus & Pilkis 197^)* Also isolated 
liver parenchymal cells facilitated the use of subcellular 
organelles by using differential centrifugation. Some 
work lias been done also on sub-particles of rat liver 
parenchymal cells such as, early changes induced by 
2-acetylaminofluorene in lysosomes (Berg 6  Christoffersen 
1974).
4 . Cell Culture
Some researchers have used cell lines in continuous 
cultivation vitro for many years. Carrel (1924) was 
the first to make a permanent;dni vitro culture of a cell 
line. Later in the 1940s and early 1950s new techniques of 
tissue culture, namely, improved media, and the use of 
antibiotics, facilitated long term cultivation of tissue 
cells and development of permanent ini vitro cell lines.
Cells w-jre not entirely invariant even when the condition of 
the culture remained constant, so, in contrast to established 
cell lines, a large number of attempts have been made to 
grow explants of fresh tissue. Cells of this latter kind 
frequently have the same characteristics as those of in vivo 
origin. Some investigators wanted to work with a particular 
property of differentiated cells not normally found in 
established cell lines. In this view the mammalian cells, 
whatever the degree of differentiation in vivo, tend to 
become de-differentiated during growth in culture and 
specialized functions are often lost (Puck, Cieciura 
& Robinson 1958 ; Salzman I9 6 1 ). Nebert (1973) 
reported the use of foetal cell cultures as an experimental 
system for predicting drug metabolism in the intact animal. 
But Holtzman et al (1972) found that cells from the
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^r.ibryonic liver all grow rapidly and are relatively 
undifferentiated with little endoplasmic reticulum*
They may constitute a %)oor model for the relatively 
stable adult hepatocytes, in studies of drug metabolism.
Fry (1 9 7 4 ) concluded that adult mammalian liver 
cells in culture offer a much better model for studying 
metabolism of xenobiotics and hepatotoxicity in intact 
adult animals'. He also mentioned that the procedures to 
obtain such cultures are : ; difficult and unreliable.
5* Homogenates.
The term "homogenate” derives from "tissue suspension" 
(potter & Elvehjem 1936; Potter 194l) . The tissue is 
usually minced and then homogenised mechanically in an 
appropriate buffer. In this process cell membranes are 
broken, the relationships between the subcellular organelles 
are lost, consistent levels of converted substrates and 
cofactors differ from those which occur in vivo and some 
interacellular components become damaged, e.g. the liver 
endoplasmic reticulum, which contains many of the enzymes 
that catalyze the metabolism of xenobiotics, breaks on 
homogenization to form microsomes. Hithout homogenization, 
it would have been difficult to find out that the most 
lipid soluble drugs are metabolized by hepa'tic 
endoplasmic reticulum or that these enzymes require 
NADPH and oxygen (Warburg & Christian 1936; Estabrook 
et al 1 9 6 3 ) • On the other hand it was impossible to 
demonstrate that hepatic microsomes convert some substrates 
to intermediates whic)i would be converted to other metabolite;
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by enzymes present in the soluble fraction. A number of 
techniques for rupturing cells have been developed including 
grinding (Page 43 ), rapid pressure change, sonic oscillation, 
freezing and thawing etc., allowing flexibility for 
preparing hornogenates. Sometimes enzyme activity appears 
to be destroyed on homogenization, e.g. either the 
liomogenization is not sufficient or the homogenization is 
too prolonged, but inactivation of drug metabolic systems 
is mostly caused by inactivation of cofactors required by 
the systems.
6. SLibcellular Fi'actions
The entire homogenate may be studied or it may be 
further fractionated into particular fractions of intra­
cellular organelles l>y subcellular fractionation. The latter 
approach facilitates tlie study of xenobiotics metabolism, 
since many of the subcellular organelles contain enzymes 
that inactivate cofactors. Schneider & Hogeboom (1950) 
reported a method for separation of hornogenates into 
nuclear, mitochondrial, microsomal and soluble fractions 
wJiich is still valuable, especially in the problem of 
determining the subcellular site(s) of metabolic reactions 
within the cell.
Fux'tlier purification of different intracellular 
particles is supplemented by centrifugation of the fraction 
in terms of density gradients. The composition of the 
density medium should be adjusted for the separation of a 
particular particle. Dallner (1 9 6 3 ) mentioned a method for 
isolation of hepatocytes by subfractionation.
This method facilitates the identification of different
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enzyme systems in subcellular particles especially in the 
liver cell, such as the system which catalyzes oxidation of 
monoamines and diamines in mitochondria (Parke I9 6 8 ) 
and redox reactions (Gillette I9 6 6 ) and glucuronide 
formation (Dutton 1 9 6 6%) by hepatic microsomes,
7• Pure Enzymes.
Studies with pure enzymes have provided valuable 
information on the mechanisms of enzyme action, e.g. in 
sequence of reactions which are regulated by multiple 
enzyme systems. Since the discovery of the mono-oxygenase 
system in the hepatic microsomal fraction, varieties of 
techniques have been eiiployed in attempts to purify it.
The first group to partially solubilize this enzyme was 
Lu & Coon (1 9 6 8 ), followed by Sato, Satake & Imai (l973)» 
and also by Griffin nt al (1973)*
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Programme of Study
The work described in this thesis was undertaken 
in order to perfect methods for obtaining large numbers 
of clearly defined populations of isolated, functionally and 
morphologically intact cells from the rat liver, in a form 
suitable for accurate analytical work, and thereby to 
compare the pathways of metabolism and pharmatékinéticsI'of 
metabolism of a number of drug substrates by the perfused 
liver, liver slices, isolated hepatocytes and tissue 
homogenate.
Reliable methods for isolating undamaged cells 
from the compact organ in large quantities are necessary, 
but this is hardly enough. The mammalian liver contains 
a variety of sinusodal cells as well as parenchymal cells 
(Knook & Sleyster 1976), In electron micrographs of 
liver fixed by perfusion, it is now possible to identify 
three cell types associated with the sinusoids - endothelbal 
cells - Kupfer cells and perir-sdnusoidal fat-storing,^ cells 
(Bloom & Fawcett 1975)» the caudate of liver also contains 
subcapsular haematopoiëtdc islânds, which are compact 
aggregates of myeloid and lymphoid cells at all levels of 
maturation, from haemocytoblasts^to fully mature leucocytes 
(Tooze, J., ID a vies H.G, I9 6 7 ), therefore it is clearly 
necessary to separate from one another, in bulk, the many 
kinds of cells which make up the liver population (Pagel^o).
There is a general problem, since no one has ever seen 
functional intact liver cells within the intact liver, how 
•intact' were any of the isolated cells ethat were produced? 
(David e_t 1975) .
3.4
Dye-exclusion tests (Erickson & Holtzman 1976) or any 
other methods (David e_t aJ. 1975) for assessment of 
viability have reported approximately the same 
percentage of hepatocyte viability. Whether these 
methods for assessment of viability are reliable or not, 
it is unclear. On the other hand Hupka & Karlar (l973) 
have mentioned a leakage of glucose-6-phosphate 
dehydrogenase from the isolated hepatocytes into the 
incubation medium. It is unlikely that the dye 
exclusion test can determine absolute viability, and in 
any population of isolated hepatocytes there will be a 
wide range of viabilities. Certainly, it is highly unlikely 
that on removal from its natural physiological environment 
the isolated hepatocyte will exhibit the same membrane 
permeability characteristics as it did in the intact organ.
However, as the test gives similar results to more 
complicated and time consuming methods, it was felt 
justifiable to use the dye exclusion test as a rapid 
indication of all viability for the purpose of this project.
Four substrates were chosen as experimental models.
These were biphenyl, ethyImorphine, thiabendazol and 
benzo(a)pyrene. All these compounds undergo microsonal 
mixed function oxidation, although each have their own 
special characteristics. Biphenyl hydroxylation ia a Type I 
reaction; ethyImorphine is also a Type 1 substrate but 
undergce&N-demethylation; thiabendazol is hydroxylated as is 
biphenyl, but it is a Type II substrate; benzo(a)pyrene is 
a cai'cingenic polycyclic hydrocarbon , which undergoes., multiple 
aromatic oxygenation.
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The methods for the determination of each of 
these enzyme activities in microsomal preparation are 
all very well established and commonly used witlxLn the 
department. Modifications had to be made to these 
methods, however, for determination of activities in 
hepatocytes and liver slices.
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Introduction
Metabolic studies using living animal s have -Made it 
possible to investigate the Cate, of endogenous and 
exogenous compounds togethe?" with the fuc"I:oi"s which 
regulate the rate oT metabolism and nature o'" the 
products. By glanc'i.ng at the litcratura, it becomes 
obvious that in vitro studies form c very i. in sort ; -i: p-? rt 
of such s tu die ; siid L'it'i'îiit t;.'-'i:i yn'n^vo s s in r:odicf 
scioncG would T)o l-'po rw-i.ble ,
The first J_n tro ex peri ric 'its wc]V' prepared with 
■whole liver, bu t later other organs and various f ra.c ti ons 
of the so organs store vised. Tl.ius , much of our present 
knowledge of biochemical pharmacology has been obtained 
by studying xenob.i otic metabolism and mode of action in 
isolated tissue preparations and comparing these findings 
with those obtained with the whole animal. In vitro studio 
are often preferable to ini vivo studies because it is 
possible to;
1. measure the relative rate of metabolism of compounds 
in various tissues
2, determine all metabolic intormediates and subseuuont1y 
tlie mechanism uf such reactions,
3» compare different oxperimen taJ. in- ' tb eds .1 » ! vi t to L/j tb 
in vivo investigations;
17
A drug introduced into the whole animal (body) must 
■pass tiirough several cellular arid suboellular niembraiies 
structurof until it reaches its site(s) of action. The 
:nain Oiiysiol ogical movements of a drug are absorption, 
distribution and excretion. The biological transportation 
patlfways are shown in Pig, 2-1,
i s i n ter II r  o t a t i o n o f vv hole o r g an e xpe riment s is oft e n 
difricult due to tlie presence of different cell types, 
membrane barriers and connective tissue etc., the so other 
techniques have been introduced to restrict the number 
of variables, and by reducing the complexity of the 
exper 1 mental system, to ease in terpretation of results •
Liver slice experiments are akin to whole organ 
studies in that, apart fhom the vascular system, all 
l.lie coustituenLs of the liver aj"e intact. However, although 
this technique is very simple, it is far inferior to liver 
I re 1' f u s i on ex p crime nt s , i n w} i j. c ii, e v e n the v a s c u 1. ar s y s t e m 
re ma ins intact and thus kinetic studies are more ineaningful.
Experiments utilising isolated hepatocytes have been 
designed to remove some of the complexities and barriers 
previously described. However, an intact cell can not 
be considered a single system as it is made up of a number 
of subcellular organelles. In order to overcome this 
difficulty, su].)cellular fractionation procedures have 
been developed so that experiments can be performed using 
just mitochondria, nuclei or fragments of endoplasmic 
reticulmn.
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Although the fund ci'ucnta Is of bn oche inis try will only 
be learned from basic experiments using onbcelluler 
fraction or enzyme preparations, it is important to 
envisage bov the., various systems fit into the whole*
Thi s complete picture can only be obtoi n f- d bye orrela ting 
results obtained from tl)o various ty no s o r c xyerlino nt 
described.
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Materials
Substrates
Biphenyl (m.p 70^) was obtained from B.D.H. Chemicals 
' Ltd., Poole, England, Thiabendazol was purchased
from Merk, Sharp & Dohme Res, Lab, Rahway N,J., U,S,A, 
Ethylmorphine hydrochloride (m,p, 123^) was supplied 
as a gift by May & Baker Ltd, , Dagenham, Englaiid,
Benzo(a)pyrene (3,4-benzpyrene) was obtained from 
the Sigma Chemical Company, U.S.A,
Cofactors & Enzymes
Nicotinamide-adenine dinocleotide (NAD), nicotinamide- 
adenine dinucleotide phosphate (NADP), adenosine 3'-triphos- 
phate (a TP) and glucose-6-phosphate were purchased from 
B.D.H, Chemicals Ltd.^ Glucose-6-phosphate dehydrogenase, 
sulphatase and collagenase (type II) were obtained from 
Sigma, Collagenase was also supplied by Worthington 
Biochemical Corporation, New Jersey, U.S.A. Ketodase was 
obtained from General Diagnostic Department, William &
Warner & Co, Ltd., Eastleigh, Hampshire, D-(U-^^C)glucose, 
D-(U-^^C)glucose-6-phosphate and sodium salt (carbonyl-^^C) . 
NADP were purchased from the Radiochemical Centre,
Araershara,
Standard compounds
4-Hydroxy-biphenyl (m.p, l62^) and Analar formaldehyde 
solution were purchased from B.D.H, Laboratory Chemicals Ltd, 
and quinine sulphate from Sigma Chemical Company, U.S.A.
4l
5-Hydroxy-thiabendazol was kindly donated by Dr. Clive Wilson 
(University of Surrey).
Solvents.
All solvents were of the Analar grade and purchased 
from B.D.H. Laboratory Chemicals Ltd,
Animals
Male Wistar albino rats(200 - 2 5 O g) were used for 
all studies. They were housed in poly-propylene cages 
and kept at 2 3 ° and 3 0^ humidity, light was on about 12 hour 
cycles. Their diet was Spratts Lab, diet No, 1 (Pasturized).
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Me thods
Preparation of biological materials 
Hepatic microsomes
Rats were killed by cervical dislocation, the livers 
removed, cleared of adhering fat and connective tissue, and 
rapidly immersed in ice-cold 1 ,13fo K C 1 solution ('^ /v) to rjemove 
unwanted blood. The livers were then dried on filter paper, 
weighed, minced with a pair of scissors and homogenized in 
cold isotonic KC1 (1 ml is equivalent to 230 mg of liver). 
Homogenization was achieved by 3 gentle return strokes in 
a glass homogenizer (size b) using a loose fitting teflon 
pestle (Potter & Elvehjem 193^)> revolved by a Stanley 
Bridges electric drill at a speed of approx. 3000 r.p.m., the 
procedure being carried out at 0 - 4° to avoid enzyme 
deactivation. After diluting the homogenate 4 fold with 
ice cold 1 ,1 3^ KCl (^/v), it was placed in 30 ml polycarbonate 
centrifuge tubes and centrifuged in an M.S.E, High Speed 
18 Centrifuge, ( 8 x 30 ml angle head rotor, at 10,000 x, g 
( 1 1 0 0 0 r.p.m.) for 2 0 minutes at 0-4° to remove the nuclei, 
mitochondria and cellular debris. The supernatant (microsomal 
supernatant) was poured carefully into a 2 3 ml polycarbonate 
centrifuge tubes at 0-4° for further centrifugation at IO3OOO x g 
(40.000 r.p.m.) for one hour at 0-4° in an M.S.E.^ Superspeed 
30 centrifuge in a 8 x 2 3 ml angle head rotor. The supernatant 
was then discarded and the microsomal pellet resuspended in 
ice-cold isotonic KCl solution and after gently homogenizing 
with one return stroke the suspension made up ( 1 ml containing 
2 3 0 mg of liver)3n the same volume as original, using cold 1 .1 3^ 
KCT solution. This microsomal suspension was used for the 
enzymic assays described below.
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Hepatocytes
Rats were anaesthetized by the intraperitoneal
administration of sodium pentobarbital solution (nembutal,
5 0 mg/kg) and the peritoneal cavity opened by a mid-line
ventral incision. The body walls were retracted by the
Spencer Wells arterial forceps to allow easy access to
peritoneal cavity. The hepatic portal vein was cannulated
with Portex pp 60 polythene tubing and the cannula held in
place by a silk ligature, A pre-perfusion of the liver with
the calcium free Dulbecco*s phosphate buffer saline (P.B,S,)
(Dulbecco & Vogt 195^) (50 ml) containing EGTA (4 m M/l.)
(Seglen 1972) and saturated with O^/CO^ (9 3(3)at the rate of
9 ml/rain, was then initiated immediately to remove unwanted
2+blood, to chelate Ca and to supply oxygen during the 
course of the hepatectomy. The liver was placed on a glass 
support platform in a constant temperature (3 7 °) cabinet 
(Fig, 2-2) and connected to the perfusion circulation and 
recirculated with Dulbecco*s P.B.S, ( 1 3 0 ml) for 10 minutes 
to remove traces of EGTA. The Dulbecco*s P.B.S, was then 
substituted with Hank*s buffered saline solution (B.S.S,) 
(Hanks & Wallace 1949) (130 ml) containing bovine serum 
albumin (B.S.A.) ( 2 2 3 0  mg), glucose (1 3 O mg) NaHCO^ (75 mg) 
and collagenase (3 7 . 5  mg) and saturated with Og/CO^ (9 5/ 5 ) 
for about 1 hour. The soft liver was placed in a glass 
Petri dish containing Hank* s B.S.S, with collagenase as 
above and chopped into smaller portions which were then 
transferred to a conical flask which was fixed in the shaking 
water bath at 37^ for IO-I3 minutes to gently release the 
hepatocytes. The liver suspension was passed through a 
coarse nylon mesh and centrifuged at 2 0 0 g for 2 minutes at
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Pigo (2^2)
Op/co
I
a ) Thermostat; (b ) Pan; (c) Water bath; (d ) Magnetic Stirrers;
(e ) Plasks; (P) Heat Exchanger; (g ) Liver perfused through 
hepatic portal vein, placed on glass support platform 
(h ) Peristaltic pump (l) Cabinet; (j) Pilter; (k ) Heating filament 
________  = connecting tubing -j- = clamp(s)
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ambient temperature. After centrifi&ation, the fluid above 
the hepatocyte pellet was removed carefully with a Pasteur 
pipette and the pellet resuspended in Hank's B,S,S« (l5 ml)
containing B,S,A, (225 mg), glucose (l5 mg) NaHCO^ (7*3 mg)
and saturated with Og/CO^ (95/3)» using a Pasteur pipette.
The washing procedure of the pellet was repeated 3 times before 
the pellet was finally resuspended in 18 ml of Hank's B.S.S,
containing the same as above.
Determination of viable population
The hepatocytes suspension (0«25 ml) was mixed with 
trypan blue (0 .50» w/v solution, 0,1 ml) and the parenchymal 
cells counted in the heamocytometer (Plate 2-1 & 2-2).
Cells successfully excluding the dye were considered viable.
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Appearance of freshly-isolated rat hepatic parenchymal cells.
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Plate 2.2
Hepatocytes suspended in medium, and exposed to trypan blue 
on the heamocytometer• Cells taking up the dye were 
considered to be non-viable.
Liver slices»
Rats were killed by cervical dislocation, the liver 
removed, cleared of fat and connective tissue and rapidly 
rinsed In Ice-cold Isotonic KCl solution to remove clotted 
blood* The liver was cleaned gently with tissue paper euid 
then weighed. The two major lobes of each liver were cut 
In two and transferred to a clean moist filter paper on the 
platform of the base plate of a hand microtome (a.H. Thomas 
6727-610, primarily designed by Deutsch 1936 and modified 
and developed by Stadl-Rlggs 1944). The cover plate and middle 
plate were fastened together and superimposed upon the base 
plate. A blade 4^ Inches long was fixed to the handle (from 
Thomas Phlla., U.S.A.) with a screw. The knife blade was 
Introduced into slot between the cover and middle plates, as 
shown below.
6727-ClO
The upper plate was then slowly pushed down onto the half 
lobe of liver and the blade moved towards It with a sawing 
motion until the blade passed through the liver section and
freed a slice. The blade was pulled from the slot, taken
from the two fastened plates, turned over, the slices were
removed by forceps and weighed at ambient temperature. Two
slices weighing about 25O rag were suspended In the Ringer's
buffer (Krebs & Henselelt 1932) prepared for the enzymic
assays as described below.
}t O
Determination of the Kupffer cell population in the 
hepatocyte preparation.
One of the physiological functions of Kupffer cells 
is phagocytosis. Therefore colloidal suspensions of inert 
material in blood can be cleared by the reticulo-endothelial 
system (R.E.S.). This has been reported for carbon (Siozzi 
et al 1953) chromium phosphate (Dobson and Jones I93I) and 
colloidal gold (Vetter et al 1934)* In order to carry out 
quantitative studies a special standard must be used. This 
must be homogenous in size of particles and well dispersed 
in the blood. The size must be such that it cannot pass 
through the capillary walls or glomeruli. Additionally, 
particles must not be toxic to the cells and the dose 
administered should not be such that its concentration 
would affect the blood circulation auid cause venous blockage.
After consideration of these problems, an experiment 
was planned to investigate the presence of Kupffer cells in 
isolated hepatocytes.
A (w/v) suspension of finely divided charcoal in 
1.13%KCl solution (w/v) was prepared and 0.2 ml injected into 
the exposed femoral vein of an anaesthetized rat. The wound 
was closed by a few stitches in the peritoneum and metal 
clips in the skin. The animal was allowed to recover from 
the anaesthetic and after 24 hours hepatocytes were prepared 
in the usual manner. Aliquots taken from the cellular 
pellet, the first supernatant and the subsequent washings 
were examined microscopically. It was found that there were 
very few Kupffer cells in the first supernatant and no 
Kupffer cells in the pellet (see plate 2-3).
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Photomicrograph of the first supernatant illustrating a 
charcoal containing Kupffer cell (arrowed) surrounded by 
parenchymal cells, (X 400)
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Partial hepatectomy for protein estimation
The rat was anaesthetized (sodium pentobarbital,
50 mg/kg, intraperitoneally) and a fine incision made 
into the peritoneal cavity just below the sternum. By 
applying pressure in the correct position it was possible 
to exclude, through the incision, the left central lobe of 
the liver. After placing a ligature around the lobe at 
the lateral vein junction, it was cut out and placed in 
the isotonic KCl solution for preparation of the microsomal 
fraction and liver slices.
Hepatocytes were obtained from the remaining portion
of the liver by the method described previously.;; Microsomes 
were then prepared from an aliquot (50$) of these cells. The total
protein content of each of these preparations- was then determined (see 
page 51a):
Determination of protein
Each liver preparation was homogenized (microsomes, 
liver slices) in KCl 1.15^ solution, and hepatocytes in 
Hank's buffer (containing glucose, B.S.A. and saturated 
by O^/CO^ (93/5 ) as described previously) and Hank's buffer 
alone (containing the same as above) were diluted 200 times.
1.0 ml of each diluted suspension was used for the protein 
estimation. The reagent required for the estimation were; 
(Lowry e_t ai 1931)
A. NagCO (2# w/v) in 0.1 NNaOH
B. Sodium potassium tartrate 1^ w/v
C. CuSO^, 3H2O 0.3# w/v
1.0 ml of each B & C were mixed immediately before use
together with 100 ml of A. 10 ml of the resulting mixture
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Protein Conversion Ratios
Protein determinations were performed on the following fractions of 
the one liver.
1. Whole liver (total protein/g liver)
2. Microsomes prepared from the whole liver (microsomal protein/g liver)
3c Isolated hepatocytes (total protein/g hepatocytes)
4. Microsomes prepared from the isolated hepatocytes (microsomal protein/g 
hepatocytes)
From these values it was possible to estimate microsomal protein coitent 
as a percentage of a total liver protein and (b) total hepatocyte protein.
i.e. (a) microsomal protein/g liver x lO O  = 25.6%
total protein/g liver 
or (i), protein in liver microsomes = 0.256 x protein in liver
(b) microsomal protein/g hepatocytes ^ lOO - 149^ 
total protein/g hepatocytes
or (ii) protein in hepatocyte microsomes = 0,149% in isolated hepatocytes
Throughout this study, protein determinations were conducted routinely 
on the whole liver and intact isolated hepatocytes only, but by using 
equations (i) and (ii) values could easily be obtained for protein content 
of liver microsomes and hepatocyte microsomes respectively.
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was added to 1.0 ml of the diluted protein solution.
After mixing and standing for I5 minutes 0.5 ml of 
Folin-Ciocalteau phenol reagent was added and the 
solutions mixed immediately. After allowing at legist 
4o minutes for the colour to develop, the optical density 
was determined at 750 nm. A reagent blank without 
protein solution was prepared from the above reagents 
and 1 ml of the distilled water.
Standards were prepared from a stock solution of 
bovine serum albumin (20 mg in 100 ml of distilled water), 
the concentrations being 20, 4o, 60, 80, 100 jig/ml.
Enzyme assays
Biphenyl 4-hydroxylation.
The liver is able to metabolize biphenyl as follows 
(Phase l).
Biphenyl
HQ
studied in this project
This compound is highly fluorescent and can be estimated 
quantitatively by using the fluorimetric technique first 
described by Mitoma ejb aJL (l95^)* The method has since 
been modified by Creaven ejfc ai (I965) and later by Neale 
and Parke (1969) and it is the latter method which was 
used as a basis for determination in the present work. 
Briefly, the 4-hydroxylation of the biphenyl substrate 
by hepatic enzymes is followed over different incubation 
periods, the hydroxylated substrate being extracted into
n-heptane with subsequent transfer into an alkaline 
solution suitable for its fluorimetric determination
Microsomes;
The incubation mixture was as follows:
Tris buffer pH 7.6 (0 .05M) O.5O ml
Biphenyl in 4^ Tween 80 (0.012M) 0.25 ml
MgCl^ (O.O5M) 0.2 0 ml
KCl solution, 1.15^ w/v in water 0,30 ml
NADP (0.005 M)
Glucose 6-phosphate (0.06m ) 1regenerating 0.25 ml
Glucose 6-phosphate dehydrogenase)
)KC1
(1.5 units) solution
Microsomal suspension 25^ ) O.5O ml
Total volume 2.00 ml
The incubation was carried out in 15 ml open screw- 
topped glass tubes for various time intervals (5, 10, 20, 
30 minutes) at 37^ in a Mickle shaking water bath 
(55 strokes/min.). The reaction was stopped by chilling 
the tubes in ice-cold water followed immediately by the 
addition of 2 M-HCl (0.5 ml) to the incubation mixture. 
The capped tubes were then shaken mechanically with 
n-heptane (10 ml) for 5 minutes, the two layers then 
being separated by centrifugation at 2000 r.p.m. (Mistral 
6L centrifuge) at 0-4° for 10 minutes. Aliquots (2.0 ml) 
of n-heptane were back-extracted with 0.1 M-NaOH (10 ml) 
and the layers again separated by centrifugation. The 
heptane layer was removed by using a Pasteur pipette
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connected to a vacuum water pump. Aliquots (2,0 ml) of* 
the aqueous phase were transferred to cuvettes (Far UV TSL, 
Thermal Syndidate Ltd.) and the pH adjusted to pH 5.5 by 
the addition of 0.5M-succinic acid (approx. 0.5 ml).
The fluorescence was then measured in a Perkin Elmer 
M.P.F. 3 Fluorimeter at wavelength 334 nm emission and 
275 nm excitation.
A blank was prepared by the addition of the substrate 
after incubation.
A standard was also prepared by the same procedure, 
o.a^ wf
that is, by addingk4-hydroxybiphenyl solution (30 mg/ml 
in 5^ ethanol) to the incubation mixture after the 
reaction had been stopped.
Hepatocytes;
( In the absence of NADPH regenerating system
This assay procedure was slightly different to 
that described for the microsomal preparation. The 
differences were as follows:
Firstly the incubation mixture contained:
Hepatocytes, suspended in Hank*s B.S.S.
(containing glucose, B.S.A. & saturated 
with Og/COg (95/5) 1.75 ml
Biphenyl in 4^ Tween 80 (0.012 M) 0,25 ml
Total volume 2,00 ml
Secondly, the incubations were carried out in 15 ml 
open screw topped glass tubes gased with O^/CO^ (95/5) 
and kept at 37*^  in a Mickle shaking water bath (55 strokes/ 
min.). The reactions were stopped at time intervals of
5, 10, 20, 30, 45 and 60 minutes,
(b) In the presence of NADPH regenerating system
Hepatocytes were suspended in Hank* s B.S.S*
as above 1*5 ml
Biphenyl in 4 ^ 'Tween 80 (0.012 M) 0.25 ml
NADP+ (0.005M) . jregenerating
Glucose 6-phosphate (0.06 M))system
Glucose 6—phosphate {dissolved in o.25 ml
)Hank*s B.S.S. 
dehydrogenase (l.5 units) )containing
as above
Total volume 2.00 ml
The experimental procedure was carried out the same as 
described above (a).
Liver slices
(a) In the absence of NADPH regenerating system
The liver slices (25O mg) were suspended in Ringer’s 
buffer (1.5 ml) (see page 48), saturated with O^/CO^ (95/5) 
and containing biphenyl solution in 4^ Tween 80
(0.012 M) (0.25 ml).
The incubation was carried out as described for 
the hepatocytes.
(b) In the presence of NADPH regenerating system
The constitution of the incubation mixture was 
changed by the addition of regenerating system. The
differences were as follows; 
Incubation mixture;
NADP’*’ (0.005 M)
Glucose 6—phosphate (0.06 M)
Glucose 6-phosphate dehydrogenase 
(l«5 units)
regenerating
system
dissolved in 
Ringer*s buffer 
saturated Op/COp
(95/5)
0.25 ml
Biphenyl in 4^ Tween 80 (0.012 M) 0.25 ml
The liver slices suspension (as above)
Further details of the procedure for this assay have 
already been described.
Determination of thiabendazol 5-hydroxylase activity
Both 2 (4-thiazolyl)benzimidazol (thiabendazol) and 
its hydroxylated metabolite
H
Thi abendazol
H
(5-hydroxythiabendazol) are soluble and fluorescent in 
aqueous solution at acidic pH, but insoluble at neutral pH. 
The assay procedure initially developed by Tocco eJb al (1965) 
is one which enables low concentrations to be measured.
In the present study, Wilson’s (l973) modified method was
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used. Incubations were prepared for various time periods, 
the solution being extracted with ethyl acetate at pH 6.0 
and the product back-extracted into 0.1 M HCl ready for 
fluorimetric determination.
Microsomes
Incubation mixture:
Phosphate buffer (0.2M) pH 7.6 0.7 ml
MgSO^ (O.IM) 0.1 ml
NADP^ (0.005 M) ^regenerating
Glucose 6-phosphate (0.06m ) j system dissolved
)in phosphate 0.2 ml
Glucose 6-phosphate {buffer pH 7.6
dehydrogenase (l*5 units) I
Substrate (0.008 M) 0.5 ml
Liver microsomal fraction 25^ 0.5 ml
Total volume 2.0 ml
Incubations were performed in a Mickle shaking water 
bath (55 strokes/min.) at 37^ for time intervals of 5> 10, 
20, and 30 minutes, the reaction being stopped by immersing 
the tubes in ice cold water followed by the addition of 
0.2M phosphate buffer (3 ml, pH 6.0). Extraction was 
accomplished by shaking with 8 ml of ethyl acetate in 
a rotary shaker for 15 minutes and the layers separated 
by centrifugation at 2000 r.p.m. (10 minutes) using an 
M.S.E. 6L centrifuge. An qliquot of the ethyl acetate 
phase (4 ml) wa6 then back-extracted into 0.1 M HCl (4 ml), 
the organic layer then being removed and discarded. 
Fluorescence measurement of 5-hydroxy-2 (4-thiazolyl)- 
benzimidazol was at \ - 330 nm excitation and X =  530 nm 
emission (using a Perkin Elmer M.P.F. fluorimeter).
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Blanks were prepared by the addition of* the substrate 
after incubation. Standards (0.001 M) were also carried 
out using the same procedure•
Hepatocytes
(a) In the absence of NADPH regenerating system
This assay procedure was slightly different to that 
described previously for the microsomal preparation. The 
differences were as follows:
Firstly, the composition of incubation mixture
Hepatocytes were suspended in Hank’s B.S.S. 
(containing glucose, B.S.A. and
saturated with O^/CO^ (95/5) 1.0 ml
Phosphate buffer (0.2 M) pH 7^6 0,5 ml
Substrate (0.008 M) 0.5 ml
Total volume 2.0 ml
Secondly incubations were carried out in 15 ml open 
screw topped glass tubes gassed with O^/CO^ (95/5) for 
various time intervals (5, 10, 20, 30, 45 and 60 minutes 
at 37° iu a Mickle shaking water bath (55 strokes/min.).
(b) In the presence of NADPH regenerating system
Hepatocytes were suspended in Hank’s B.S.S.
as above 1.0 ml
Phosphate buffer (0.2 M) pH 7#& 0.3 ml
NADP**^  (0.005 M) ^regenerating
Glucose 6—phosphate (0,06M} \system dissolved
)in phosphate 
Glucose 6-phosphate {buffer (0.2 M)
dehydrogenase (l.5 units) <pH 7.6 0.2 ml
Substrate (0 .OO8 M) 0.5 ml
Total volume 2.0 ml
^  o  e  o  *r% a  1 1 v »  /a t*t o  A  /4 *1 n 4- ^  /4 A  ^  ^  .« V^. ^  ^  ^  ^
Liver slices
(a) In the absence of NADPH regenerating system
The liver slices (2 5 O liig) were suspended in Ringer's 
buffer (1 . 0  ml) (see page 4 8 ), saturated with O^/CO^ (9 5 / 5 ) 
and containing thiaVjendazo 1 in 0,1 N HCl (O.OOB M) (0,5 ml)*
The incubation procedure was as described for the hepatocytes.
(b) In the presence of NADPH re-generating system
The constitution of the incubation mixture was changed 
by the addition of regenerating system.
Incubation mixture
NADP (0 , 0 0 5  M) )regenerating
Glucose- 6“phosphate (0,06m ) jsystem dissolved
Glucose 6-phosphate dehydrogenase ) in Ringer's buffer 0.2 rr
(1 , 5  units) jsaturated O^/CO^ (95/5)
Substrate (0.008 M) 0,5 "
Liver slices suspension (as al>ove)
The experimental procedure has been described 
previously.
Determination of 3,4-Benzpyrene hydroxylase activity 
by using microsomal preparation
This carcinogenic polycyclic hydrocarbon can be 
rapidly hydroxylated by liver enzyme to give various 
hydroxylated metabolites, many of which are difficult to 
determine specifically# In this case, the total
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fluorescent products, mostly 3-hydroxybenzo(a)pyrene, 
■was determined.
Benzo(a)pyrene
This enzyme assay was first developed by Conney ejfc al 
(1957) and then modified by several other workers 
(Dehnon ejt ^  1973» Kuntzman ejb I966, Wattenberg I962 
and etc.).
Microsomes.
The procedure was performed as quickly as possible 
since the product is photosensitive and fluorescence 
may be lost. Incubations were performed for various 
time intervals up to 30 minutes and the metabolite 
extracted into hexauie and back extraction into M-NaOH, 
for immediate fluoriraetric determination.
Incubation mixture
Glucose 6-phosphate dehydrogenase (3 units) 0.5 ml
Glucose 6-phosphate (0.03m ) 0.2 ml
NADP (4 mg/ml) 0.1 ml
NAD (4 mg/inl) 0.1 ml
ATP (O.OIM) 0.2 ml
Nicotinamide (0.6m ) 0.2 ml
KCl (2M) 0.1 ml
MgCl^ (0.1 M) 0.1 ml
Phosphate buffer (o.l M of KH^PO,, ,K^HPO^) ,
pH 7.4 1.0 ml
Substrate (50 jig) in acetone 0.1 ml
Microsomal suspension (25/^ 0.4 ml
Total volume 3*0 ml
Incubations were performed in 15 ml glass capped tubes
(during incubation without cap) at 37° in a Mickle shaking 
water bath (speed 55 strokes/min.) for various time 
intervals (5 » 10, 20 and 30 min) and the reaction terminated
by cooling in ice and by the addition of cold acetone (2 ml).
Hexane (8 ml) was added to each tube and the mixture
extracted by a shaking in a rotary mixer for 20 minutes.
The phases were separated by centrifugation at 2000 r.p.m. 
(M.S.E. centrifuge fitted with a 6 x 25O ml swing-out rotor)
for 5 rain. Aliquots (4 ml) of the organic phase were back
extracted with M-NaOH ( 5 ml) in a shalcing rotary mixer, 
and centrifuged as before. The upper layer then being 
removed by aspiration. Immediately the fluorescence was 
measured at 382 nm excitation and 5IO nm emission on a
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Perkin Elmer M.P.P. fluorimeter, A blank was carried 
through the same procedure, with the substrate being 
added after termination of the reaction. The standard 
(quinine sulphate, 0.5 ml stock solution 0.33i6mg/ml)w as added to 
4.5 ml H^SO^ (0 .05M) and read at 340 nm excitation and 
445 nm emission. This standard gave a fluorescent 
reading equivalent to 0.01412 nmol of 3-hydroxybenzpyrene 
per ml and the amount of product could therefore be 
determined.
Hepatocytes
(a) In the absence of regenerating system
This assay procedure was slightly different to that 
described for the microsomal preparation. The differences 
were as follows:
Firstly, the incubation mixture contained:
Hepatocytes suspended in Hank's B.S.S*
(containing glucose and B.S.A. and
saturated with O^/CO^ (95/5) 2.3 ml
Nicotinamide (0.6 m) 0.2 ml
Substrate (50 ng) in acetone 0.1 ml
Total volume 3.0 ml
Secondly, the incubations were carried out in 
15 ml open screw topped glass tubes gassed with
(95/5) and kept at 37° in a Mickle shaking water bath 
(55 strokes/min).
The reactions were stopped at time intervals of 
5, 10, 20, 30, 45» 60 minutes.
Liver slices
(a) In the absence of a regenerating syst em
The liver slices (2 3 O mg) were suspended in Ringer*s 
buffer (1 , 6  ml) (see page4 8 ), saturated with O^/CO^ (9 5/5 ) 
and containing benzo(a)pyrene ( 3 0  mg) in acetone (0 * 1 ml) 
and nicotinamide (0 .6m) (0 * 2 ml).
The incubation was carried out as described for the 
hepatocytes.
N-Demethylation of Ethylmorphine
The enzymic N-demethylation of ethylmorphine can be 
followed by measuring the amount of formaldehyde following 
the oxidation of the methyl moiety.
H
OH OH
+  HCHO
CH2CH3
Ethylmorphine
Formaldehyde is reacted with semicarbazide to give
methylene semicarbazone. 
0
H-C
\ H
+ NH NHCONH HH C = NNHCONH^+H^O
which is then coupled with the Nash reagent at 37 to 
develop a coloured yellow complex (Nash 1933)*
HCHO + CH COCH^COCH
NH^COOCH^
H3
0-
CH
OH
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Microsomes
The modified incubation mixture (Holtzman ^  ^  I968)
Tris-buffer, pH 7.6 (0.3M) 0.5 ml
MgCl^tO.lM) 0.1 ml
Ethylmorphine hydrochloride (0.06m ) 0.25 ml
Semicarbazide hydrochloride at pH 7.0 0.2 ml
Glucose 6-phosphate (0,06m) ^regenerating
NADP (O.OO5M) jsystera in
KOI solution 1»0 ml
Glucose 6-phosphate dehydrogenase 
(1.5 units)
Microsomal suspension (25^) 0.5 #1
Total volume 2.55 ml
Incubations were carried out in 15 mi open screw topped 
glass tubes for various time intervals (5 > 10, 20 and 30 
minutes at 37^ in a Mickle shaking water bath (55 strokes/ 
min). The reaction was stopped by cooling the tubes in 
ice-cold water followed immediately by the addition of 
15^ zinc sulphate (1.0 ml) and a mixture (2 :l) of saturated 
solutions of barium hydroxide and sodium borate (l.O ml) 
to the incubation mixture. The capped tubes were then 
centrifuged at 2000 r.p.m. (Mistal 6L centrifuge) at 
0-4° for 10 minutes to deposit protein. Aliquots of 
supernatant (2.0 ml) were added to fresh Nash reagent 
(2.0 ml of 4M-amonium acetate containing 4 ml of 
acetylacetone/litre) and were then incubated for 
40 minutes in a shaking water bath (as above) at 37°#
The yellow coloured complex was determined at 4l2 nm 
in a Cecil 272 spectrophotometer.
64
Blank and standard (0.3mmol of H-CHO) determinations 
were carried; out using the s’atne procedure, '
Hepatocytes
(a) In the absence of regenerating system
This assay procedure was.slightly different to that 
described for the microsomal preparation. The differences 
were as follows:
Firstly the incubation mixture containeds-
Hepatocytes suspended in Hank*s B.S.S.
(containing glucose, B.S.A. and saturated 
with Og/COg (95/3) 2.1 ml
Ethylmorphine hydrochloride (0.06m ) 0.25 ml
Semicarbazide hydrochloride 2^ at pH 7.0 0.2 ml
Total volume 2.55 ml
Secondly, the incubations were carried out in 15 ml 
open screw topped glass tubes gassed with 0^/00^ (95/5) 
and kept at 37° ih a Mickle shaking water bath (55 strokes/ 
minute). The reactions were stopped at time intervals of 
5, 10, 20, 30, 45 and 60 minutes.
(b) In the presence of NADPH regenerating system
Hepatocytes were suspended in Hank’s B.S.S.
as above 1.1 ml
Ethylmorphine hydrochloride (0.06m ) 0.25 ml
Semicarbazide hydrochloride 2^ at pH 7*0 0.2 ml
Glucose 6-phosphate (0.06m ) )regenerating
NADP+ (0.005M) system (Hasobed
) in Hank’s B.S.S, i q ml 
Glucose 6-phosphate dehydro- Containing as
genase (l.5 units) above
Total volume 2.55 ml
The experimental procedure was carried out as described 
above (a).
Liver Slices
(&) In the absence of NADPH regenerating system
The liver slices (23O mg) were suspended in Ringer’s 
buffer (1.6 ml) (see page 48), saturated with O^/CO^ 
(93/5) and containing ethylmorphine hydrochloride (0 .06m) 
(0.25 ml), and semicarbazide hydrochloride 2^ at pH 7#0 
(0.2 ml).
The incubation was carried out as described for the 
hepatocytes.
(b) In the presence of NADPH regenerating system
The constitution of the incubation mixture was 
changed by the addition of regenerating system. The 
differences were as follows:
Incubation mixture :
NADP'*' (O.OO5M) )regenerating
Glucose 6-phosphate (0.06M) j system dissolved
)in Ringer’s 1*0 ml
Glucose 6-phosphate d e h y d r o - ^
genase (l,3 units) j(95/3) ^ ^
Ethylmorphine hydrochloride (0.06m ) 0.25 ml
With the liver slices suspension
Further details of the procedure for this assay have 
already been discussed.
Determination of Cytochrome P-450
The method for measurement of Cytochrome P-450 has
been described by Sladek and Mannering (1966). The 
microsomal suspension (25^ in isotonic KCl) was 
diluted with 0.2M phosphate buffer pH 7*4 (l:2 v/v) 
and a 10 ml aliquot placed in a cuvette# A few crystals 
of sodium dithionite were added to reduce the 
haemoproteins present. After mixing by inversion 
2 or 3 times, two, 3*0 ml aliquots of the mixture were 
taken into 2 small tubes, one being saturated with carbon 
monoxide and the other used as a reference. Each were 
then placed in separate cu vettes. The difference 
spectra between the two seunples was then determined 
between 390 nm and 550 nm, using a Pye Unieam SP1800 
Double Beam Recording Ultraviolet Spectrophotometer.
The Cytochrome P-450 was taken to be proportional to 
the differences in the absorbance at 450 nm - 490 nm.
Electron microscopy of hepatocytes
About 25 years ago, the first electron micrographs 
of hepatic cells were published by Dalton ^t al (1950)
Since then this field has continued to develop, and
now electron microscopy is one of the most important tools
of the biologist.
This elegant technique has been used for cytochemistry, 
autoradiography (Caro, I961) and also in pathology and 
toxicology to study cellular and subcellular changes 
and thus to correlate relationships between cellular 
ultrastructure and biochemical characteristics.
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Method for preparation
The method for preparing isolated liver cells was as
described previously* The same samples from freshly prepared 
hepatocytes were washed three times with Milloning 
buffer (1961) pH 7*7^ (containing 5*4^ glucose, 2.5^ NaOH 
and 2.26^ NaHgPO^), fixed by different concentrations of 
acetone as follows:
30^ acetone and 70ÿ buffer for 24 hr.
60^ acetone and 4oÿ buffer for 12 hr.
90^ acetone and 10^ buffer for 3 hr.
100^ acetone for at least 5 hr.
Then one drop of each cell suspension was put on a 
round slide, covered by heavy metal (gold) and made 
ready for electron microscopy. The exposures were 
developed and printed (Plate 2-^-4) • This method was used 
also for hepatocytes after incubation in the absence and 
presence of substrate for 15 minutes (plates 2-5 and 2-6),
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Plate 2-4
X 5600
X 2250
Scanning electron micrograph of isolated hepatocytes.
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Plate 2-5
X 5 1 5 0
&
X 2200
Scanning electron micrographs of isolated hepatocytes 
after incubation at 37° for I5 minutes in the absence of 
substrate s.
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Plate 2-6
X  5100
y
X 2100
Scanning electron micrograph of isolated hepatocytes 
after incubation at 37° for 15 minutes in the presence 
of substrate.
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CHAPTER III
HEPATIC MICROSOMAL MIXED-FUNCTION OXIDASE ACTIVITY IN 
LIVER MICROSOMAL PREPARATIONS, ISOLATED HEPATOCYTES 
AND LIVER SLICES.
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Chapter III
HEPATIC MICROSOMAL MIXED-FUNCTION OXIDASE ACTIVITY IN 
LIVER MICROSOMAL PREPARATIONS, ISOLATED HEPATOCYTES AND 
LIVER SLICES.
Most drugs are metabolized in the liver and the most 
common routes of drug metabolism involve oxidation, 
reduction, hydrolysis and conjugation. Very often, a drug 
is subjected to several competing pathways simultaneously, 
and the extent of formation of various metabolites depends on 
the relative rates of the various interactions. In vitro 
metabolism reduces the possibility of this occurring, and 
the use of microsomal preparations reduces this phenomena 
even more.
The metabolism of any drug depends upon the biophase 
(i.e. sufficient drug molecules must be present in the
immediate vicinity of enzyme), the affinity of the, drug for the
I
receptors and the compound's intrinsic activity(s) or 
efficacy (i.e. drug stimulus; maximum stimulus of the drug 
in the various sub-cellular organelles).
As drugs can exert such a variety of actions and can 
interfere with the functions of many enzymes, it is probable 
that drug receptors are scattered throughout the entire cell, 
but the most important part exposed to the drug is the cell 
surface. This is the primary receptor and should exert a 
definite activity until the drug can pass across the membrane 
into the cell (ref. Chapter Vl). Within the cell, there 
is also the possibility of metabolism by the electron 
transport systems aided by either NAÛPH cytochrome c reductase
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of the endoplasmic reticulum, by mitochondrial cytochrome b^, 
or by both. Consequently, it may be misleading to study 
the metabolism of drugs with microsomes alone. The use of 
isolated hepatocytes may solve some of these problems.
When estimating drug metabolism at the cellular level 
(parenchymal cells) , it is necessary to remember that the 
body of the tissue (liver slices) is composed of a large number 
of non-parenchymal cells (Hapka & Korber 1973) and noncellular 
components in addition to parenchymal cells. Some of the 
metabolism takes place in the hepatocyte which is one aspect 
of metabolism. On the other hand metabolism also occurs in 
the noncellular elements of the tissue. It would therefore be 
a very serious error if this action were to be neglected.
Some molecules cannot permeate cell membranes and therefore 
become distributed in the extracellular space. This is 
evident because pathological conditions of tfche extracellular 
tissue respond to drug treatment (Schubert and Hamerman I968; 
Matthews 1975)#
It is possible that the kinetics of enzymatic oxidation 
(hydroxylation) and reduction may be affected by the integrity 
of the cell and the relationship of sub-cellular organelles 
with the ce11-sap.
In order to investigate the different extents of 
metabolism in various model systems, it was decided to study 
the pharmacokinetics of certain drugs such as biphenyl 
(fungistatic), thiabendazol (anthelminhhc), benzo(a)pyrene 
(carcinogen) and ethylmorphine (narcotic, analgesic), using 
liver slices, isolated hepatocytes and hepatic microsomal 
preparations. In each case liver from male Wistar albino
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rats (200 - 250 g) was used, and modified methods of 
Schneider & Hogeboom (1950), Seglen (1972) and Leloir 
& Munoz (1938) were used for the preparation of microsomal 
fractions, isolated hepatocytes and liver slices, 
respectively.
The methods for determination of the various enzyme 
activities were as described by Creaven, Parke & Williams 
(1965) for biphenyl hydroxylation, by Tocco ejb al (1985) 
for thiabendazol hydroxylation, by Kuntzman al (1966) 
for benzo(a)pyrene hydroxylation, and by Holtzman et^  al (I968) 
for ethylmorphine N-demethylation, although slight 
modifications were made for the hepatocyte and liver slices 
assays, in which the incubations were performed in Hank’s 
buffered saline solution (containing, per 100 ml, 1.5 S  
of bovine serum albumin and O.lg of glucose) and 
Krebs-Ringer buffer solution, respectively, with no 
cofactors being added in either case. Concentrations of 
the products formed were determined in the media at regular 
time intervals, and results are expressed in terms of n mol 
of product produced per rag of microsomal protein. Protein 
was estimated by the method of Lowry al (1951)> ( details 
described previously. Chapter II)•
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Table 3.1
Comparison of rat '.Tiver biphenyl 4-hydroxylase activity 
in different preparations.
Preparation
Period of
Incubation
Minutes
Micro some s Hepatocytes Slices
5 7.4 ± 0 . 3 10,6 ± 1.7 0 . 7 8 + 0 . 1
10 12.8 ± 0.7 12.4 ± 1.3 1.38± 0.1
20 l6.6 ± 1 . 1 l6.6 ± 1.9 9.3 t 1.9
30 l6.6 ± 1.1 19.9 ± 5.7 19.7 ± 2.7
43 20.3 ± 8.2 21.3 ± 0.1
6b. 1 7 . 0  ± 7.1 12.8 ± 0 . 7
me an + S. E .M. = n mol metabolite formed/mg microsomal protein.
Table 3.2 ■-
Coinpari son of rat liver thiabendazol hydroxylase activity in
different preparations
Preparation
Period of 
Incubation 
Minute s
Microsome s Hepatocyte s Slices
5 3.5 ± 0.1 4.0 ± 0.8 0.6 ± OJ
10 8.4 t 0.2 7.0 ± 0.1 1.7 ± 0.3
20 9.7 ± 0.8 11.3 ± 1.7 3.4 ± 0.3
30 9.6 ± 0.4 12.0 ± 1.7 4.1 ± 0.5
43 12.0 ± 1.5 5.9 + 0.3
60 10.0 ± 2.0 6.7 + 0.4
me an + S . E , M . = n mol metabolite formed/mg microsomal protein
73
Table 3.3
Goinpaj-lson of rat liver benzo (a) pyrene hydroxylase activity 
in different preparations
Period of
Incubation
Minutes
5
10
20
30
45
60
Preparation
Micro somes
■45 * 5.7‘ 
. 6 0  + 5.7 
’6o + 6,6 
70 ± 10
Hepatocyte s
0.9 ±  0.1 . 
{l.2 + 0.1: 
1.5 ± 0.2
1.7 ± 0.1; 
1.9 + 0.2
1.8 ± oil
Slices
•,3.8 ±1.6 
:9.6 +0.9
■20.0 ± 1.1; 
\34.o ±4.o; 
•31.6 ±13.4
56.0 ±22
me an + S.E.M. = p mol metabolite formed/mg microsomal protein.
Table 3.4
Comparison of rat liver ethylmorphine N-demethylase activity 
in different preparations.
Period of
Incubation
Minutes
5
10
ao
30
43
6o
Preparation
Microsomes
223 + 19
438 + 2 3  
7 3 1 + 68 
840 + 38
Hepatocytes
14.6 + 2.2
20.3 + 1.7
21.6 + 2.0
23.1 + 2.0
29.2 + 3.8
3 4 . 4  + 2.6
Slices
31 + 2 
1 1 3 + 12 
1 9 7 + 17  
1 9 7 + 26  
216 + lb 
2 7 4 + 8
Mean + S.E.M. = n mol metabolite formed/mg microsomal protein.
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Pig. (3-1) - Biphenyl 4-hydroxylation by rat liver slices,
free hepatocytes and microsomal preparation*
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Fig. (3-2) - Thiabendazol 5-hydroxylation by rat liver
slices, free hepatocytes and microsomal preparation.
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Fig* (3-3) - Benzo(a)pyrene hydroxylation by rat liver
slices, free hepatocytes and microsomal preparation*
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Fig. (3-4) - Ethylmorphine N-demethylation by rat liver
slices, free hepatocytes and microsomal preparation.
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Pig (3“5) Rate of thiabendazol hydroxylation and 
its relationship to cell viability 
(in presence and absence of substrate).a0
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Fig (3 -6 ) Rate of biphenyl hydroxylation and its
relationship to cell viability (in presence 
and absence of substrate).
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Fig. 3-7
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3-OH benzo(a)pyrene
Non-linear response in fluorimetric determination of 
benzo(a)pyrene hydroxylation - as at low concentration 
these products are almost completely bound to protein.
This accounts for the unusually high increase (lOO to 300 fold) 
seen after enzyme induction (Pouts),
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RESULT
Biphenyl Hydroxylation,
The biphenyl 4-hydroxylase activities of liv^r slices, 
hepatocytes and microsomes were all very similar. However, 
whereas the activités of hepatocytes and microsomes were 
almost identical during the first 20 minutes of incubation, 
that of the liver slices was much less and did not attain 
the activities of the other preparations, until 3 0 minutes 
incubation. The maximum activities (21 nmol/mg microsomal 
protein) of the liver slices and hepatocytes were obtained 
after 43 minutes, whereas with the microsomes the maximum 
( 1 7 nmol/mg microsomal protein) was attained after only 
20 minutes. The rate of the enzyme reaction after 3 minutes 
falls in hepatocytes and microsomes. However the rate of 
the reaction in slices accelerated after 10 minutes and 
falls again after 20 minutes.
Thiabendazol Hydroxylation
Again thiabendazol hydroxylase activities of hepatocytes 
and microsomes were very similar, and the least activity was 
in the slices. However, the activities of hepatocytes and 
microsomes were almost identical during the first 20 minutes 
of incubation, the liver slices was much less and did not 
reach the activities of the other preparation at any time 
of incubation. The maximum total activities of the 
hepatocytes (12 nmol/mg microsomal protein) occurred after 
30 minutes, for microsomes (9*7 nmol/mg microsomal protein 
occurred after 20 minutes, but in slices did not occur until
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after 1 h. The rates of thiabendazol hydroxylation in microsomes 
and slices are fast for the first 10 minutes and after that 
decrease, but for the hepatocytes the rate decreases after the 
first 5 minutes.
Benzo(a)pyrene hydroxylation
The benzo (a)pyrene hydroxylase activity of microsomes was 
much higher than in slices and hepatocytes (especially in the 
first 5 minutes), and was least in hepatocytes. The maximum 
activity in microsomes was after 30 minutes approximately 
(70 pmol/mg microsomal protein) for the slices after about 60 
minutes (56 pmol/mg microsomal protein) and for the hepatocytes 
about 45 minutes (1.9 pmol/mg microsomal protein). The rate of 
benzo(a)pyrene hydroxylation in microsomes was rapid during the 
first 5 minutes but then decreased. In slices this rate was slow 
for the first 30 minutes and then decreased further; for hepatocytes 
the rate was much slower and again decreased after the first 5 
minutes (see Conclusion).
N-Demethylation of ethylmorphine
The N-demethylase of ethylmorphine activity of microsomes was 
much higher than that of slices and hepatocytes, and this remained 
so throughout the incubation period. Hie maximum total activity 
in microsomes occurred after 30 minutes (840 nmol/mg microsomal 
protein), in slices it occurred after 60 minutes (274 nmol/mg microsomal 
protein) and in hepatocytes after 60 minutes (34 nmol/mg
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microsomal protein)# The rate of this enzyme activity in 
microsomes and slices increases for the first 10 minutes 
and then slows down, whereas in hepatocytes it decreases 
after the first 5 minutes.
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CONCLUSION
Pry ejk aL (1975) reported that biphenyl is toxic to 
hepatocytes in high concentrations but the results shown 
(Table 3.1 and Fig. 3*l) were obtained using a high 
concentration (O.OOI5M). Pigs. 3*5 and 3*6 show that even 
non-viable cells have hydroxylation enzyme activity.
Moreover, it should be emphasised that the cellular integrity 
and viability (as measured by Trypan blue-exclusion) is not 
necessarily critical to the hydroxylation of xenobiotics.
It is the interaction of subcellular organelles that is 
important, and this may depend on cytochrome P-450 
(Orrenius ejt al 1975)» electron carriers, e.g. flavoproteins 
(Masters ejb al I9 6 5 ) , electron donors (cofactors) or all three. 
This has been proved by Denks ^  aJL (1 9 7 6 ), using microsomes 
and mitochondria, for N-demethylation and formation of 
formaldehyde.
As shown in Pigs. 3*3 and 3 . 4  and Tables 3*3 and 3*4, 
the maximum activities of some enzymes were observed in the 
microsomal preparation. These findings would appear to 
generally negate the hypothesis that cellular integrity is 
always necessary for optimum rates. However a number of 
other factors must be taken into consideration. Pirstly 
the results obtained are consistent with the possibility 
that the non-parenchymal cells (Kujffer cells) and 
extracellular constituents of the liver are major 
contributors to the metabolism of benzo(a)pyrene and 
ethylmorphine. Hupka and Karlar (1973) have shown that 
the Kupiler cells contribute to the dealkylation of 
ethylmorphine but they do so only in a minor way,
contributing only about 1?^ of the total enzyme activity,
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As the major extent of metabolism occurs in the 
parenchymal cells, when using liver slices, the drug has to 
gain entry to receptor sites, via some barriers (i.e. 
blood sinusoid, connective tissue, non-parenchymal cells) 
there may be some delay in the intact parenchymal cells of 
liver slices before maximal enzyme activity would be reached. 
This delay may not be experienced when using microsomal 
preparations and isolated hepatocytes.
The most interesting aspect of the present work, however, 
may be the high activity rate of biphenyl and thiabendazol 
hydroxylase observed in hepatocytes, these being even 
greater than those observed with microsomal preparations. 
Biphenyl and thiabendazol hydroxylase have the same 
requirement for NADPH as the other enzymes studied, but may 
be able to utilize NADH more readily than can the others.
The enzyme activities decreased after about 3 0 minutes. This 
may be due to leakage of cofactors into the incubation media, 
in addition to enzyme degradation. It is also probable that 
metabolites are metabolised further, e.g. glucuronide 
conjugation.
Alternatively, the size of molecules and different 
biological transport mechanisms may be an important factor 
in drug metabolism in isolated hepatocytes (see Chapter Vl).
In addition to biological transport (size of the 
molecule) of benzo(a)pyrene and products, it is necessary 
to mention a personal communication of J. Pouts. He has 
emphasised the non-linear response obtained in the 
fluorimetric determination of benzo(a)pyrene hydroxylation.
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as at low concentration these products are highly bound 
to proteins present in the incubation medium. This 
accounts for the unusually high increases (lOO and 
5 0 0 fold) seen after enzyme induction (see Fig. 3-3 and 
3-7 and Table 3-3).
Consequently the present results possibly demonstrate 
different classes of viability, which occur in different 
experiments of the same enzyme assay (see S.E.M. in 
Table 3-1 to 3-4). This is discussed more fully in 
Chapter IV.
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Microsomal oxygenation requires NADPH. It is therefore 
customary to add a NADPH-regenerating system to microsomes. 
The constituents of one such NADPH-regenerating system are 
NADP^, glucose-6-phosphate and glucose-6-phosphate 
dehydrogenase. Warburg described NADP* and glucose-6 - 
phosphate dehydrogenase. Brodie et al (l955) showed that 
a similar enzyme system localized in hepatic microsomes 
was responsible for the metabolism of many drugs.
Many substrates are known which utilize NADPH in 
their metabolism by hepatic microsomes microsomal enzymes, 
e.g. trimethylamine (exogenous compound) stimulates NADPH 
oxidation by an amount equivalent to the amount of 
trimethylamine oxide formed (Baker & Chaykin I9 6 2 ); 
tryptamine and tryamine (endogenous compounds) are 
hydroxylated by the same system (Lemberger ejt aT 1 9 6 5 }. 
Hexobarbital was found to increase NADPH oxidation in 
accordance with stoichiometric expectations (Trivus &
Spirtes I9 6 5 ). However, Gillette (1 9 6 6 , I9 6 9 ) found that 
some drugs had no effect on NADPH oxidation whereas others 
had a greater effect than could be explained by the 
metabolisms of the drugs. Ernster and Orrenius (1 9 6 5 ) 
demonstrated a 1 :1 : 1  stoichiometry of oxygen consumption, 
NADPH disappearance, and formation of formaldehyde, from 
the oxidative déméthylation of aminopyrine. However,
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Estabrook and Cohen (1 9 6 9 ) found that the stoichiometry 
was not the fundamental criteria for mixed function 
oxidative reaction. For each mole of NADPH oxidized 
during the formation of each mole of formaldehyde, two 
moles of NADP were formed. The function of NADPH as only 
one of the coenzymes providing the reducing equivalent for 
cytochrome P-450 via the electron transfer system was 
reported by Sih, Tsong & Stein (1 9 6 8 ); Sih (1 9 6 9 ).
Most oxidation reactions catalyzed by microsomal 
enzymes require oxygen and NADPH (Garfinkel 1958» 
Klingenberg 1 9 5 8 ). On the other hand flavoproteins 
have been recognised as hydrogen and electron carriers 
between pyridine nucleotides and cytochromes (Masters 
et al 1 9 6 5 ).
NADH
NADPH i
I j'*>cyt .b,4- •
SOH
Scheme proposed the contribution of NADH and cytochrome b^ 
in electron transport chain (Estabrook & Cohen 19^9)*
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Recent studies (Waterman & Mason 1970) on the 
oxidation-reduction potential of cytochrome P-4^0 confirm 
the conclusion that only a single electron is required for 
the reduction of cytochrome P-450. It is now well 
established (Prough & Burke 1975) that the flavoprotein 
NADPH~cytochrome c reductase (cytochrome P—450 reductase) 
is necessary for the transfer of reducing equivalents from 
NADPH to cytochrome P-450. Orrenius & Ernster (1964) 
reported that the NADPH cytochrome c reductase was the 
rate-limiting component of the oxidative déméthylation 
system.
Hupka & Karlar (1975) noted a leakage of glucose-6— 
phosphate dehydrogenase from isolated cells into the 
incubation medium. This obviously also occurs with liver 
slices. It is assumed that the interior cells are 
undamaged but leakage may occur due to surface cell 
disturbance upon slicing. It was observed that maximal 
mixed function oxidase activity was not obtained until the 
medium was saturated with the dehydrogenase. Moldeus e_t aX 
(1 9 7 4 ), studying the metabolism of alprenolol in isolated 
hepatocytes, similarly found a requirement for NADPH.
Bickel & Gigon (1 9 7 1 ) reported that in the absence of an
NADPH-regenerating system imipramine N-demethylase activity 
of rat liver slices is only 5 0^ of maximum.
From this previous work and the conclusions of 
Chapter III, the need for supplementation bf the external 
medium by addition of cofactor (NADPH) was considered likely.
Hence similar experiments were carried out for hepatocytes
and liver slices by using a NADPH-regenerating system of
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the same concentration as that used for microsomal 
preparations (Fig. 4.1 to 4.3 and Table 4.1 to 4.3)
In order to find out which component or combination 
of components of the NADPH-regenerating system is the 
most important in xenobiotic metabolism by isolated viable 
hepatocytes, experiments were carried out using hepatocytes 
at the optimum period of enzyme activity ( 3 0 minutes).
The various coenzymic components and combination of 
components are shown in the results on Table 4.2.
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Table 4,1
Goini->arison of rat liver biphenyl hydroxylase activity in the
presence of NA])PH regenet ati.ng system in different px"e par at;
Préparât1on
Period of 
incubation 
li.inu tes
M i c 1rosomes He pat Oiij y IG s Slices
3 7.4 + 0,3 24.0 +• 3 . 5 4.7 + 0 . 9
10 12,8 ± 0,7 59.5 1- 9 . 7 1 7 . 0 f 3.2
20 l6.6 ± 1.1 38.6 + 11.0 20.4 4- 6 , 0
50 l6,6 ± 1.1 7 7 . 4 + 13.4 21,8 4“ 2 . 7
43 84,1 + 9 . 3 18.3 4* 5 . 8
60 9 6 . 9 + 8.7 1 9 . 3 + 8 .3
mean Z S . E . I-U = n mol metabolite formed/mg microsomal protein. 
Table 4.2
Comparison of rat liver thiabendazol hydroxylase activity 
in the presence of NADPiI regenerating system in different 
preparations.
Preparation
Period of
Incubation
Minutes
3
10
20
30
43
microsomes
5.3 ± 0.1 
8,4 ± 0 , 2
9.7 ± 0,8
9 . 6  + 0.4
6o
Hepatocytes
13. ± 1. '; 
17.5± 4.7 
2 0 .1+ 4.5 
20.7± 4.3 
22.2+ 3.8 
23.9+ 2.8
Slices
5.6 ± 0,9
4.8 ± 1,5 
6,2 ± 0,9
6.8 ± 1,0
6,9 ± 1.0
6,5 t 1,8
i^ iean + S.E.M, = n mol metabolite formed/mg microsomal protein
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Table 4.3
Coiiip-ar.lsori of rat liver e tiiy l.norplii jie-N-cUunetiiy lase activity 
in the j)re sc nee .of NADPH rege tie ca ( i iig system in different 
Cl c parati. uns .
Pc ri ch of
j're narat j on
Incubation 
il i n Li t e s
Hier’O some s lie p;itocy te s Slices
5 223 ± 1 9 167 90 45 ± 19
10 458 ± 2 5 201 + 4l 135 ± 21
20 731 ± 68 216 + 29 200 î 17
30 841 ± 38 227 42 314 ±119
45 256 + 7 395 ±138
6o 322 + 2 390 ±129
mean + S.E.M. = n mol me tabo 1ite formed/ ing micr 0 somal pro t'
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Table (4.5) Different enzyme activities of hepatocytes 
in the presence of NADPH regenerating system.
Preparation was performed by using hypotonic 
Hank's B.S.S.*; the dye exclusion test showed that all 
the cells were non-viable.
Period of Biphenyl
incubation 4-hydroxy- 
minutes. lase
5
10
20
30
45
6o
32.1
3 2 . 2
34.8
6 1 . 8  
41.8 
42.0
Thiabend­
azol 5- 
hydroxylase
7.8
12.2
11.0
11.4
11.3
11.2
Ethylmorphine
N-demethylase
221
443
443
720
1,080
834
unit = n mol metabolite formed/mg microsomal protein.
* composition of hypotonic Hanks B.S.S.
NaOl 
K 01 
CaCl^
MgSO^.THgO
MgCl2,6H20
Na2HP0^,2H20
KH^PO^
Bovine serum 
albumin 
collagenase
g/1 H2O
8.0
0.4
o.i4
0 . 1 0
0 . 1 0
0 . 0 6
0 . 0 6
15
0 . 2 5
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Fig (4-l) Biphenyl 4-hydroxylation in isolated rat
hepatocytes (in the presence and absence of 
NADPH regenerating system) and microsomal 
preparations.
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Fig (4-2) Thiabendazol 5-bydroxylation in isolated rat 
hepatocytes (in the presence and absence of 
NADPH regenerating system) and microsomal 
preparations.
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Fig (4-3). Ethylmorphine N-demethylation in isolated rat 
hepatocytes (in the presence and absence of 
NADPH regenerating system) and microsomal 
preparations.
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Pig(4-1 ) - Biphenyl 4-hydroxylation in rat liver slices
(in the presence and absence of NADPH 
regenerating system) and microsomal preparations
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Fig (4-2) Thiabendazol 3"-dydroxylation in rat liver slices 
(in the presence and absence of NADPH 
regenerating system) and microsomal preparations.
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Fig (4-3) N-demethylation of ethylmorphine in rat liver
slices (in the presence and absence of NADPH
regenerating system) and microsomal preparations
a
•H
Q)
+)
o
u
A
H
a
Bo
(0
o
u
o
•H
E
W
s
Ti0
S
uo
«H
(0
0
-P
•HHI
O
■3
-P
0
S
O
0 
r—I
O
E
800
600
400
200
40 30 60205 10 30
Period of incubation (mins.)
The values are the means of at least 3 experiments
■— -- ■ slices in the presence of NADPH regenerating
system; o—  _, slices in the absence of NADPH
regenerating system and %------ % , microsomes. For S.E.M.
values see Table (4-3 and 3-4)
103
Fig (4-4) Biphenyl 4-hydroxylation in non-viable 
isolated rat hepatocytes compared with 
hydroxylation in viable hepatocytes (in the 
presence and absence of NADPH regenerating 
system) and microsomal preparations.
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Pig (4-5) Thiabendazol 3-dydroxylation in non-viable 
isolated rat hepatocytes compared with 
hydroxylation in viable hepatocytes (in the 
presence and absence of NADPH regenerating 
system) and microsomal preparations.
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Fig (4-6) Ethylmorphine N-demethylation in non-viable 
isolated rat hepatocytes compared with 
hydroxylation in viable hepatocytes (in the 
presence and absence of NADPH regenerating
q system) and microsomal preparations.
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Results
As shown in Fig (4.1, 4.2 and 4.3) and Table (4.l) 
for biphenyl and thiabendazol hydroxylation and 
eihylmorphine N-demethylation there appeared to be 
increased activities of the enzymes in hepatocytes in 
the presence of an NADPH-regenerating system compared with 
hepatocytes alone. But for ethylmorphine N-demethylation 
there is still less activity in the hepatocytes than 
observed in the microsomal preparation. Rapid enzyme 
activity mostly occurred in the first 30 minutes, especially 
between 5 - 10 minutes which is approximately linear. In 
the case of slices, Fig (4.1, 4.2, 4.3) and Table 4.1 the 
activities for all three substrates are greater when a 
NADPH-regenerating system supplements the reactions. But 
for N-demethylation of ethylmorphine even with the addition 
of the NADPH-regenerating system the hepatocytes show less 
activity than the microsomal preparation. The rates of 
the hydroxylations, both in the presence and absence of 
NADPH-regenerating system, diminish after approximately 
3 0 minutes.
Table 4.4 shows the optimum of drug metabolism obtained 
by the addition of glucose-6-phosphate and NADP. This 
appeared to stimulate biphenyl hydroxylation and 
ethylmorphine N-demethylation but not thiabendazol 
hydroxylation. Glucose-6-phosphate dehydrogenase showed 
no significant effect.
As shown in Fig (4,4 and 4.3) the rate of enzyme 
activity in non-viable, lysed cells, in the presence of a
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NADPH-regenerating system, is higher than with microsomal 
preparations. In the case of biphenyl 4-hydroxylase it 
is even higher than for hepatocytes in the absence of a 
NADPH-regenerating system, but for thiabendazol 
3-hydroxylase non-viable cells plus a NADPH-i’egenerating 
system is approximately the same as viable cells without 
NADPH-generation. Fig, 4.6 shows the higher activity of 
ethylmorphine N-demethylase obtained with lysed cells in 
the presence of a NADPH-regenerating system in comparison 
with viable hepatocytes but in the presence and absence 
of NADPH-regeneration.
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Conclusion
The above results show that a NADPH-regenerating 
system stimulates drug metabolism reactions in intact 
cells. For biphenyl hydroxylation and ethylmorphine 
N-demethylation the endogenous generation of NADPH in 
isolated viable hepatocytes is inefficient and added 
glucose-6-phosphate and NADP stimulate the hydroxylation 
reactions•
Erickson & Holtzman (1976) reported that the rate of 
N-demethylation of ethylmorphine. by isolated hepatocytes 
decreased with time. Denk ejt aX (l97^) found that 
the reduction of formaldehyde, by mitochondrial enzyme(s) 
occurred when microsomes and mitochondria were used together. 
Therefore the determination of formaldehyde does not 
necessarily give the amount of dealkylation. This aspect 
was examined by using hepatocytes and liver slices in the 
presence and absence of a NADPH-regenerating system.
The differences in the rate of metabolism in hepatocytes 
and slices were not significant in comparison with the 
microsomal metabolism (Table 4.3). Erickson & Holtzman 
(1 9 7 6 ) mentioned that appare nti low rates of ethylmorphine 
N-demethylation might be due to the removal of products 
from the reaction site of the membrane by glucuronidation.
As this has been tested, the positive answer with this 
substrate could be rare (Chapter V). The above emphasises 
the relationship of the subcellular organelles. Also it 
could be the possibility of relationship between two 
cytochromes (c and b^) as electron carriers.
109
Addition of excess glucose 6-phosphate dehydrogenase 
to the hepatocyte medium, which would prevent this leakage, 
had no effect upon the drug metabolism activity of the 
cell (Table 4-4), However, when NADP and glucose 6-phosphate 
were added to the medium, the enzyme activities were greatly 
enhanced, suggesting that these factors may be leaking 
from the cells. Alternatively, the results could be 
interpreted as meaning that there is no leakage at all 
but that NADP and glucose 6-phosphate can be taken up by 
the cell with a resulting increase in activity (Chapter Vl). 
It is concluded that there is no ideal method for measuring 
the cell viability (Bhuyan ejt al 197&; Harris & Griffiths 
1974; Waster & Hofer 1974; Dolan 1 9 6 3 ),
Comparison of the high enzyme activity of biphenyl 
hydroxylation and ethylmorphine N-demethylation, obtained 
when non-viable cells were used (Table 4-3) in the 
presence of a NADPH-regenerating system, with the 
activity of intact hepatocytes shows that the integrity 
of the cells is not essential for in vitro drug metabolism. 
So, cytochrome P-430 with NADPH cytochrome c reductase 
(electron carrier and donor), and possibly also cytochrome 
b^ (NADH), are required for the redox reaction.
It may be that glucose 6-phosphate and NADP are 
cofactors affecting type I (biphenyl and ethylmorphine) 
substrates rather than those of type II (thiabendazol).
This was shown by using viable hepatocytes, non-viable 
cells and slices. It is known that during microsomal
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hydroxylation substrates may accept one of the two 
electrons required from NADH thus deriving the energy 
from glycolysis and the citric acid cycle. It is also 
known that some substrates are more able than others 
to accept the second electron from NADH rather than 
NADPH. It is possible, therefore, that for thiabendazol
5-hydroxylation, which is known to occur very easily 
(whereas biphenyl and ethylmorphine undergo hydroxylation 
with difficulty), the maximum contribution is from NADH, 
glycolysis and Kreb cycle, instead of from glucose
6-phosphate and NADP,
The variation in quantity of metabolites may be due 
to differences in total cell populations (Erickson & 
Holtzman 1976). '-V' ■
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CONJUGATION OF XENOBIOTICS
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CHAPTER V
■CONJUQATjPON DE XENOBIPTICS
The process of conjugation of drug molecules involves 
their reaction with other molecules to form esters, amides 
or other substitution products (Boyland I9 6 1 ). One or both 
reacting molecules participate in an activated state.
Usually, the active molecules are derived from metabolic 
processes of the body. The most common examples are 
"active acetate (Leibman 6  Anaclerio I9 6 2 ), sulphate (Nose 
and Lipmann 1 9 5 8 ) and glucuronic acid (Dutton 1 9 6 6 a). 
Occasionally, the foreign compound or its metabolites 
(e.g. benzoic acid and phenylacetic acid) are activated,
(such asLybinding^ to coenzyme A (Co a ). The active products 
are usually formed by mitochondrial action in the liver cells 
A transferase accomplishes the transfer of the activated 
molecule to the other molecule of the conjugation pair.
Recently Huston (l970) defined conjugation as the 
biosynthetic process by which foreign compounds, with 
functional group(s) and their products from phase I 
metabolism, are linked to endogenous components (as above) 
to form a so-called conjugates.
These reactions are catalysed by group-transferring 
enzymes (Brodie, Gillette & La Du 1958; Dutton I9 6 I; Van 
Lensden 1 9 6 3 )* In this group of reactions, various effects 
may occur following detoxication, by virtue of large 
alterations in properties. Two important properties of 
bioactive molecules are (i) intrinsic biochemical activity
and (ii) lipid solubility. The former usually depends on
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drug structure, and so conjugation may result in loss 
of activity. The latter is important because lipid 
soluble compounds may pass through biological membranes 
by passive diffusion to sites of action. Conjugation 
usually results in the formation of ions, which because 
of their charge and bulky hydration sheaths, do not have 
the same mobility in tissue. Eventually, the general 
result(s) of this reaction(s) is that the molecules 
become more polar, less lipid-soluble and therefore 
more readily excreted from the animal body (detoxication).
The most important conjugation reactions are as 
follows:
Table (5-l).
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Conjugation Major target group Deficient species
1, Glucuronic acid
2, Sulphate
3, Glycine
ornithine
glutamine
4, Acétylation
5. Glutathione
6, Méthylation
-OH, -COOH, -NH 
>HII, -SH
cat, gunn rat
aroiiiatic-GH, aromatic pig
-NH^, some alcohols
aromatic -COOH 
aromatic alkyl -COOH
aromatic -COOH
aromatic -CH^ -COOH
aromatic -NH ^ , 
hj^drazines, some 
aliphatic -NH_ 
SO;NH^
certain birds and 
reptiles
mammals
non-primates
dog
aromatic hydrocarbons guinea pig, man 
-Cl, -Dr, -F, -NOg
aromatic -OHj-NH^,
■ >NK, , -SH
Table (3-1) (Mandell972)
ll4
Glucuronic acid conjugation
This conjugation reaction is more fully related to 
the present project. Also because of the general 
availability of glucose in the (biological) system, 
glucuronide formation is one of the more common routes 
of drug metabolism for many drugs.
Conjugation with glucuronic acid occurs with 
alcohols resisting oxidation (Williams 1959) and with 
phenolic groups.
COOH
-OH
UDPGA+
Transgluc-
uronylases
Salicylic
acid
COOH
0-Carboxyphenyl- 
glucuronide 
(ether type)
COO.C^HgO^
0-hydroxybenzo^' 
glucuronide 
(ester type)
Carboxyl groups, especially if they are located on an 
aromatic nucleus or close to it, are in most cases converted 
to glucuronides (e.g. see above). The same happens to 
carboxyl groups with a heavy -carbon-substitution, e.g. 
trimethylacetic acid and tertiary butylacetic acid 
(Dziewitkowski & Lewis 1945). Amines, e.g. aromatic 
compounds reported by Axelrod, Inscoe & Tomkins (1958) 
are conjugated to thiol compounds, e.g. diethyldithio— 
carbamyl glucuronide, formed in the metabolism of 
disulfiram (Antabuse) (Parke 1968).
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Mechanism of reaction
Glucuronide conjugation involves reaction of the drug 
or its biotransformation product with D-glucuronic acid 
(Dutton 1961 & 1966b; Hartiala I961), The reaction does 
not take place directly, but requires the activation of 
glucuronic acid by the synthesis of the coenzyme donor 
uridine diphosphate glucuronic acid (UDPGa ),
Glucose -1-phosphate + UTP
-4UDPG + PgO.
UDPG + 2NAD UDPGA + 2NADH-
dehydrogenase ^
UDPGA + ROH ROC H O. + UDF
transferase o 9 6
Glucuronide formation occurs mainly in the liver but 
also in other tissues such as gastrointestinal tract, 
kidney and skin. The enzymes synthesizing UDPGA are 
found in the soluble fraction of tissue (isselbacher 
Charahas & Quinn I962) but the trans-glucuronylases are 
located in the microsomal fraction.
Substrate for the reaction. Many types of drugs form 
glucuronides. The most common examples are alcohols and 
phenols which make "ether type" of glucuronides. Aromatic 
but also aliphatic carboxylic acids form "ester type” of 
glucuronides. Various amines, especially aromatic compounds 
form N-glucuronides (Axelrod ejt ^  1958) some of which may 
even form spontaneously, i.e. without the catalytic action 
of a glucuronyl transferase. Certain thiol compounds form 
S-glucuronides. Some endogenous substrates (i.e. bilirubin, 
oestrone, thyroxine, testosterone) conjugate with glucuronic 
acid similarly to foreign organic compounds.
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Some factors affecting glucuronide formation; Several 
factors influence the glucuronide conjugation, i.e. sexual 
hormone effect: for example, the male rat produces more
of the conjugate than ffemale, testostrone enhances 
glucuronide formation in the female rat whileoestradiol 
reduces that in the male. Also th^^xine administration 
may lead to increased glucuronyl transferase activity.
This enzyme is also increased by microsomal drug 
metabolism inducers. On the other hand the microsomal 
enzyme inhibitor, SICP3 2 3A inhibits the. enzymes in vivo, 
and phenylbutazone inhibits glucuronide formation 
in vitro. But the pharmacological significance of these 
effects is till unclear (Smith & William-I9 6 6 ).
By referring to the above and also bearing in mind 
that the cell is an active intact single unit (of an organ), 
it is reasonable to expect that most of the organs 
reactions, as well as phase II reactions, should take 
place in it. Glucuronide transferase is a latent enzyme, 
the activity of which is enhanced by surfactants.
Experimental
Experiments were carried out using biphenyl as a 
substrate (biphenyl in 4^ Tween 80 (0.l4 |imol) (35 mM)
(4 filit.) . The method for incubating the substrates with 
hepatocytes was as described previously. After the 
extraction of 4-hydroxy biphenyl by n-heptane, 2ml extract 
was used for the determination of 4-hydroxy biphenyl 
(Phase l). The rest of solvent was discarded. The 
remaining aqueous solution (approximately 2 ml) was 
incubated with 2 5 0 units of B-glucuronidase (impurity 
sulphatase) 0.1 ml and acetate buffer pH 4.6 (0 . 9  ml)
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After overnight incubation, extraction and determination 
of 4-hydroxy biphenyl was carried out as previously 
described (page 52 ). •
This procedure has also been carried out with 
thiabendazol and ethylmorphine as substrates.
Results »
As shown in Fig. (3*l) conjugation of the hydroxylated 
metabolites occurred and conjugated as well as the free 
metabolite were present. The maximum conjugate formation 
(glucuronide and sulphate) occurred after 20 mins. then 
fell as did the amount of free metabolite. This was 
changed by the addition of an NADPH regenerating system 
(Fig. 5-2) and the maximum conjugation occurred at 
45 mins. The conjugate formation increased rapidly in 
the absence of a NADPH regenerating system, but in the 
presence of NADPH it increased gradually.
At higher concentrations (3 moles in O .25 ml) there 
was no evidence of biphenyl conjugation. Also, no matter 
what concentrations of thiabendazol or ethylmorphine were 
used, their conjugation could not be located.
Conclusions
Hepatocytes are able to undertake Phase II reactions. 
The condition of conjugate formation has similarities with 
the whole organ and microsomal preparations (i.e. in high 
concentration of biphenyl, inhibition of conjugation 
occurred and this did not occur when biphenyl concentration 
was low) • It should be mentioned that the toxicity of
biphenyl affected directly the conjugation reaction and
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Fig. 5-1
Biphenyl 4~hydroxyIation by rat free hepatocytes
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Fig. 5“1 shows that the 4-hydroxybiphenyl formed is 
mostly conjugated. This reaches a maximum at 20 min 
incubation. This thereafter declines - possibly due to 
further hydroxylation metabolism, i.e. to 4,4 -dihydroxy-
I
biphenyl, o— — O , Free metabolites O—  ■ .^ o , total
f _ -
metabolites and a  a conjugated metabolites#
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Fie. 5-2
Biphenyl 4-liydroxylation by rat free hepatocytes (in the 
presence of NADPH regenerating^ system) .
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Fig. 5“2 in the presence of cofactors hydroxylation is more 
rapid than in their absence, and less is conjugated. Maximum 
is reached in 10 - 20 min. The decline in 4 -hydroxybiphenyl 
(total) indicates further hydroxylation. The smaller amount 
of conjugated 4 -hydroxybiphenyl in the presence of 
cofactors suggests that further hydroxylation is accelerated
by presence of cofactors, e----- ® » Free metabolites ; a_____ a ,
conjugated metabolites and ®—  — , total metabolites.
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not the Phase I reaction (Fry ejt aT I9 7 5 ) (see Chapter III).
Reference to Fig. 5*2 shows that by the addition 
of an NADPH-regenerating system the rate of conjugate 
formation is reduced, although the rate of formation 
of total metabolites remains unaffected.
In the case of thiabendazol conjugate formation 
may occur in the N-position of the molecule (Axelrod et al 
1 9 5 8 ) and there is no barrier to the measurement of
5 -hydroxy thiabendazol, fluorimetically.
In the case of formaldehyde formation from ethylmorphine 
two possibilities arise, namely, formaldehyde is trapped 
rapidly by seraicarbazide or semicarbazide inhibits 
glucuronide conjugate formation. Alternatively, it is 
possible that mitochondrial enzyme present in the 
hepatocyte preparations are responsible for reduction of 
the formaldehyde released from the ethylmorphine (Denk 
et al, 1 9 7 6 ), thus giving rise to artificially low results.
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CHAPTER VI
ISOLATED HEPATOCYTE VIABILITY AND CELLULAR PERMEABILITY 
Introduc ti on
Before commencing investigations on the viability 
of the isolated hepatocytes, certain terms should be 
defined and discussed.
What is a membrane? In a symposium held in I9 6 I,
Smith discussed at length the arguments for the existence 
of the plasma membrane as a structural entity. He 
concluded, reasonably enough, that the evidence was 
strongly in favour of this idea, and he suggested that 
the boundary between the cell and the outside world was 
merely an interface between two continuous phases (Smith I9 6 2 ). 
Today it seems extraordinary that such an argument ever 
could have taken place. The existence of the plasma membrane 
and other biological membranes is fundamental to modern 
cellular biology, and the idea that internal membrane 
systems constitute the basic cytoskeleton and circulatory 
system of the cell is firmly established. Membranes have 
been isolated free of other cellular components, weighed, 
fractionated, analysed, photographed and studied by a 
number of different techniques. Unfortunately, despite 
this knowledge, it is still difficult to give a simple 
definition of a biological membrane. With this scant 
knowledge I should define plasma membrane as follows:
The plasma membrane contains the cell surface. This 
organelle is responsible for the environmental regulation 
of substances into and from the cytoplasm. This regulation
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also applies to many foreign compounds. Thus, the 
distribution of xenobiotics between the extra- and 
intrra-cellular space will be affected by the plasma 
membrane. There are many enzymes in the plasma membrane 
which may affect greatly the integrity of the cell.
Also the location of the receptors in the membrane 
control the changes of the chemical environment. The 
following aspects of the plasma membrane should be 
considered pharmacodynamically.
a. The structure of the plasma membrane
The membrane had earlier been considered only in 
connection with barrier functions, and much attention 
has been paid to explaining these barrier functions on the 
basis of physical phenomena. The preferred permeation of 
lipid-soluble molecules over non-lipid soluble molecules 
was thus explained by the presence of a lipid layer in the 
plasma membrane. Preferred permeation of certain non-lipid 
soluble molecules was assumed to reflect a relationship 
between size of pores in the membrane and the diameter 
of the molecules and so on.
All cells have a thin, fragile, lipoprotein membrane 
which regulates permeability between the cytoplasm and 
the outer environment. The usual thickness is about 
5 0 - 100 5. The precise structural arrangement of the 
components in the membrane is not known, although seveial 
models have been proposed. Gortner and Grendel's (1 9 2 5 ) 
original proposal for a bimolecular lipid membrane was 
elaborated in subsequent years by Danielli & Davson (1935)î
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Davson & Danielli (1952). The latter model proposes 
that the membrane is composed of two oriented layers 
of lipid and the two layers of protein arranged 
perpendicularly to the cell surface. The polar ends of 
the lipid molecules are directed outwards, and this 
lipid core is covered on each side with a layer of 
protein bound to the lipids by ionic forces. This 
model was deduced from studies of membrane permeability, 
electrical properties, X-ray diffraction patterns 
(Finean et al 1953)» and other physiochemical measurements. 
It seemed to be confirmed by electron microscopy, which has 
shown the presence of three parallel layers. It was 
further proposed that all cellular membranes had identical 
structures (Robertson I9 6 0 ). This suggestion was that 
they consisted of two dense bands, each 20 - 3 0 wide 
and separated by 2 5 - 4o A° (Robertson 1959). This 
structure has been suggested for the organelle membrane 
as well (apart from the membranes of the nucleus and the 
mitochondria which were double).
In opposition to the above model is one proposed by 
Collander and Barlund (1933) in which the membrane is 
believed to be riddled with many pores which connect the 
cytoplasm with the water surrounding the cell. These 
pores were specified as being permeable to water and to 
small hydrophilic particles such as K^, urea and Cl .
This type of membrane was later defined as a mosaic of 
lipid cylinders immersed in a protein meshwork.
An ingenious hypothesis to explain the action of 
neurohormones has been offered (Watkins I965). It is
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suggested that the choline portion of the acetylcholine 
molecules causes the choline portion of phosphatidylcholine 
(lecithin) to dissociate from its complex with protein in 
the cell membrane and hence create a pore through which 
sodium ions can enter. Similarly Y-aminobutyric acid 
and glutamic acid are supposed to dissociate the protein 
complexes of phosphatidylethanolamine and phosphatidylserine, 
respectively.
Calcium plays a part in regulating the permeability 
of cytoplasmic membranes and micro-incineration shows a 
high content of calcium. It has been suggested that the 
bivalent calcium ion decrease;permeability by linking 
with two anionic groups in the membrane (Danielli, 1937)• 
Thiol (mercapto) groups in protein can also increase the 
stability of membranes, e.g. by oxidation to disulphide 
bonds.
The general plausibility of this model was supported 
by the chemical analysis of membranes prepared by 
differential centrifugation of cell homogenates which 
showed that the bulk of membrane material is lipid and 
protein in different proportions (Emmelot ejt ai 1964).
Various cellular and sub-cellular membranes have been 
shown to contain large amounts of phospholipid, cholesterol, 
and neutral lipids, in association with protein. Rat 
liver plasma membrane, for example, contains approximately 
40^ lipids, over half of which are phospholipids and 
approximately 60^ protein (Benedetti and Emmelot I9 6 8 ).
A substantial part of the protein (20 - 2 5 )^ is soluble
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in physiological saline and appears to be antigenically, 
electrophoretically, and ultracentrifugally heterogeneous 
(Emmelot & Benedetti I9 6 7 ). Three different classes of 
phosphoproteins have been characterized in rat liver 
plasma membranes by Blat & Harel (1 9 6 9 ).
Other plasma membranes and the membranes associated 
with mitochondria and the endoplasmic reticulum have 
characteristic types and amounts of lipid and protein 
(Rouser e_t ai I968, Korn 1969). The constitution of cell 
membrane has been reported as being 8 5^ protein and 10^ 
lipid (Emmelot e_t ai 1964).
Recently, reinvestigations and reinterpretations of 
physiochemical data and electron micrographs, and the 
utilization of more modern techniques, have suggested to 
some that the "unit membrane" concept outlined by 
Robertson (1 9 5 9 ) is an over-simplification. As suggested 
above, cellular membranes differ significantly in their 
chemical composition. It is possible that they also differ 
in structure, depending on their chemical composition and 
physiological faction. For example, the orientation 
of lipids may be as a globular or micellar substructure 
embedded in protein, rather than a bilayer. Moreover, 
some recent suggestions for a plasma membrane model raised 
by Korn (1969), Bendetti and Emmelot (I968) and Guidotti 
(1976) are concerned about a protein-protein layer rather 
than lipid-lipid layer interaction as the basis for 
membrane structure. Whatever the eventual architecture 
of the membrane may be, it is probable tliat the membrane * s 
lipid content accounts for its relative permeability to
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lipid-soluble solutes; the membrane proteins are involved 
not only in membrane structure but are associated with the 
specialized specific transport mechanisms,
b , Permeability of the plasma membrane.
It is evident that the distribution of a chemical 
agent within a tissue is highly dependent on its ability 
to penetrate semi-permeable membranes. The classical 
concept of the cytoplasmic membrane was that it was static 
in behaviour, something like a dialysis sac. In recent 
years, much attention has been directed to the latent 
dynamic properties of the membrane, such as phase-reversal 
and the processes akin to enzyme activity that it exhibits 
(e.g, energy-dependent transport processes).
Membranes have been classified according to their 
observed functions. This classification covers four main 
types as follows;
1, The "Type I" membrane, which seems to be the most 
common, is involved with migration of molecules between two 
phases, i,e, diffusion. Molecules that have a high acid/ 
water partition coefficient diffuse fastest through this 
type of membrane, Collander (1 9^7 ) showed that when various 
organic phases are used to determine a series of partition 
coefficients no change in the order of magnitude of the 
coefficients occurs although the absolute figures differ. 
However, the order does change if any of the solutes can 
hydrogen bond with one organic solvents and not with another, 
e,g, phenols with oleyl alcohol and dodecane respectively 
(Burton, Clarke & Gray 1964),
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The rate of migration of molecules across the membrane 
depends upon the permeability and also the difference 
between the two concentrations (0 ^-0 2 ) on either side of 
the membrane* This procedure may be expressed by Pick’s 
Law ;
IÇA(C -Cp)
Rate of diffusion = ---^-----
where (k) is the diffusion constant, (a) is the interface 
area, (d) is the thickness of membrane. The diffusion 
constant is dependent on a number of factors, e.g. 
molecular size, shape of the molecule, degree of ionization 
and lipid solubility. For more detail of the kinetics 
of diffusion see Laidler & Shuler (19^9) and Zwolinski, 
Eyring & Reese (1 9^9 ),
The permeation of drugs across the membrane also 
requires consideration. The compounds are often more 
lipid-soluble than water-soluble when in the non-ionized 
form, but are highly water-soluble and less lipid-soluble 
when ionized. As a result the non-ionized form permeates 
more readily across cell membranes, whereas the ionized
form does not (Shore, al 1957). The degree of
ionization of an electrolyte is related to the dissociation 
constant (K^) of the compound and the pH of the medium, 
and can be easily calculated from the Henderson4Hasselbach 
equation;
C
for acids, pH = (log K + log —^— )
for bases, pH = (log K + log —  )
^ non
where C and C. are the concentration of nonionized and non i
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ionized forms respectively. The effect of pH on diffusion 
is very important because most drugs are either weak acids 
or bases.
The passage of large molecules, such as proteins, 
through 'Type I* membranes, seems to take place by 
pinocytosis,
2 ) The 'Type 2' membrane differs from Type I in 
requiring a carrier in the membrane. There are a number 
of instances where a substance moves according to existing 
gradients, ending with equal concentration on both sides 
of the barrier. Energy consumption is not necessarily 
involved in such a process. Various mechanisms have 
been proposed for this type of membrane and Danielli (1954) 
called it "facilitated diffusion" while others have called 
it "mediated transport". Many ideas have been suggested 
for possible ways in which a carrier acts as an 
intermediary in mediated transport. It could be assumed 
that a carrier is bound to the drug from the outside of 
the membrane and that the carrier-drug complex moves 
across the membrane and releases the drug at the inner surface, 
The carrier then returns to its original place to complete 
the cycle of reactions (Willermat & Rosenberg I9 6 1 ).
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Mediated transport of compound(s) across a membrane can be 
catalyzed by carrier (c) in forming the freely diffusible 
complex C-S (Werkheiser & Moran 1973)-*
3) The passage across a *Type 3* membrane occurs against 
a concentration gradient. In this case active carrier 
transport is involved, in which the penetrating molecule 
is believed to combine with a carrier, as in * Type 2*.
This process requires the consumption of energy by the 
cell, so has been called an energy-dependent process,
or a "biological pump". Energy for the above system is 
derived most likely from adenosine triphosphate (ATP), 
linked to energy-yielding metabolic processes.
4) For ’Type 4* membranes, diffusion occurs through pores 
The radius of these pores was calculated to be about
4 - 8 (Csaky I9 6 5 ). Some of the small anions such as 
chloride can pass through aqueous channels lined with the 
positively charged groups. Channels also exist for
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non-electrolytes, and the size of* the pores can be 
estimated from the size of the largest molecule which 
penetrates. One of the best examples of a ’Type 4* 
membrane is the glomerular membrane in Bowman’s capsule 
of the kidney.
In consideration of the above and of the conclusion 
of Chapter IV, it was decided to investigate whether 
NADP and glucose 6-phosphate could penetrate the hepatic 
cell? Bickel & Gigon (l97l) reported that these cofactors 
cannot penetrate cell membranes. Two different methods 
for quantitative determination were employed.
1. Determination of the penetration of the cofactor 
into the hepatocytes by using rapid separation technique 
(Hems, Lund & Kerbs 1975)
2. Determination of the penetration of the cofactor 
into the liver by using liver perfusion (Miller e_t al 1951» 
Regen 1975)
131
EXPERIMENTAL
1,1 Uptake of D-(U-^^C) glucose 6-phosphate by hepatocytes.
The experiment was carried out using 8 tubes each 
containing 1.3 ml of hepatocyte suspension and also 
cofactors and substrates as follows:
1. glucose 6-phosphate (0.06 M) 0.25ml + 0.25ml of medium
2 . glucose 6-phosphate (0 . 0 6  M) + NADP (0.005 M)
0 . 2 5  ml + 0 . 2 5  ml of medium Total volume 2.0 m
3* glucose 6-phosphate (0 . 0 6  M) + NADP (O.OO5 M)
0 . 2 5  ml + 0 . 2 5  ml of biphenyl (0.012 M)
Total volume 2.0 n
4. glucose 6-phosphate (O.O6 M) + NADP (O.OO5 M)
0 . 2 5  ml + 0 . 2 5  ml of ethylmorphine (0 . 0 6  M)
Total volume 2.0 n
Similarly, the above mixtures were used for the other 4 tubes 
to set up the experiment in duplicate, then were added
0 . 5  (i Ci of C^^ -glucose 6-phosphate to all 8 tubes. The 
blanks were set up using the same procedure but in the 
absence of labelled glucose-6-phosphate.
The tubes were incubated in a water bath at 37°C and 
shaken for 30 minutes. The contents of each tube were 
then transferred to a centrifuge tube (Fig. 6-I) for the 
rapid separation of hepatocytes from the incubation medium 
by centrifugation at I5OO g for 1 minute. As shown,
Fig. (6-I), the centrifuge tube has two chambers which
contain two different layers. The upper layer
was removed with a Pasteur pipette and transferred to
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Fig (6-1)
17 mm
40 m m
-Cell su sp e n sio n
•13 m m
A ir b u b b le
4% N aCI
40 mm
• 2  m m  b o r e  cap illa ry  
‘tu b in g
A ir  b u b b le
Bulb (v o lu m e , 
1 .5  m l a p p ro x .)
Tube for rapid separation of hepatocytes from 
incubation medium. (Hems, Lund & Krebs 1975)*
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another test tube and the rest, which contained NaCI yjo 
and HCIO^ 4^ (Hems eib aT 1973) (approx, 2 ml) and also 
a few hepatocytes were transferred to another test tube, 
and then 0,1 ml of each tube was added to a vial 
containing 0,2 ml of HCIO^ 6 0^, it was then capped and 
then 0,2 ml of H^O^ (3 0^ w/v, 95.6 volume of available 
oxygen) was added. The volume was brought to 2,0 mis 
with distilled water. Scintillation fluid (l8 ml) 
containing toluene (2 parts) synperonic N X P (l part) 
and 2,5 diphenyloxazole (0*53^) was added to vials 
containing the 2,0 ml sample. The samples were then 
counted for radioactivity (LKB 1210 Ultrobeta Liquid 
scintillation counter), thereafter activity was calculated 
in term of (iCi/ml and [iCi/g (Table 6-1),
1,2 Uptake of (Carbonyl-^^C) NADP by hepatocytes
The experiment was carried out using 8 tubes each 
containing 1,5 ml of hepatocytes suspension and also 
cofactors and substrates as follows
1, NADP (0,005 M) 0,25 ml + 0,25 ml of
medium Total volume 2,0i
2, NADP (0 . 0 0 5  M) + glucose 6-phosphate
(0 , 0 6  M) 0 , 2 5  ml + 0 , 2 5  ml of medium " " "
3 , NADP (0 , 0 0 5  M) + glucose 6—phosphate
(0 . 0 6  M) (0 , 2 5  ml + 0 . 2 5  ml of
biphenyl (0.012 M) '» '• "
4, NADP (0 , 0 0 5  M) + glucose 6-phosphate
(0 , 0 6  M) 0 , 2 5  ml + 0 , 2 5  ml of
ethylmorphine (0 . 0 6  M) »* »• "
Similarly, the above mixtures were used for the other
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4 tubes to make the experiment in duplicate, then was 
added (carbonyl -^^C) NADP(0.1 or0.5fiCi)to all 8 tubes. 
The blanks were made up using the same procedure in the 
absence of ^^C-NADP,
All other procedures were similar to test 1.1.
The results are shown in Table (6-2),
1,3 Uptake of D-(U-^^C) glucose by hepatocyte
The experiment was carried out using 12 tubes each 
containing 1,5 ml of hepatocytes suspension and also 
cofactors and substrates as follows;
1, medium (containing Hank*s B.S.S, glucose)
0,5 ml Total volume 2,01
2, glucose 6-phosphate (0 , 0 6  M)
0 , 2 5  ml + 0 , 2 5  of medium ” " "
3 , N A D P  (0 , 0 0 5  W) 0 . 2 5  ml + 0 , 2 5  ml
of medium " '* "
4, glucose 6-phosphate (0,06 M) + NADP
0.005 M) 0.25 ml + 0.25 ml
of medium ” ” "
5, glucose 6-phosphate (0,06 M) + NADP
(0 , 0 0 5  M) 0 , 2 5  ml + 0 , 2 5  ml
of biphenyl (0.012 M) ” » "
6, glucose 6-phosphate (0,06 M) + NADP
(0 . 0 0 5  W) 0 , 2 5  ml + 0 . 2 5  ml of
ethylmorphine (0 , 0 6  M) m u  "
Similarly, the above mixtures were used for the other 6 tubes
for duplicates and then D-glucose labelled 0,5 Ci
(^^C) was added to all 12 tubes. The blanks were made up
l4by the same procedure but with omission of C-glucose, 
and the procedure followed as before. Results are shown 
in Table (6-3).
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2, DETERMINATION OF PENETRATION OF THE COFACTOR IN THE 
LIVER BY USING LIVER PERFUSION.
2.1. UPTAKE OF D-(U-^^C) GLUCOSE 6-PHOSPHATE BY THE LIVER.
Liver Perfusion
The liver is known to be a major site of drug 
hydroxylation and oxidation. In the hydroxylation 
mechanism cofactors are indispensable.
The isolated perfused liver can be maintained under 
physiological conditions. This would appear to make it 
an ideal system for the studying of the effects of cofactors. 
The ability of the liver to take up a particular material 
from the perfusate is well known (Miller e_t aJL 1951 ) » 
and this is a property of the hepatocytes which comprise 
the majority of liver tissue.
Perfusion Technique; The apparatus (jplate. 6-1 ) was 
essentially that described by Miller e_k al (1 9 5 1 ) but 
modified by other workers. The perfusion medium was 
pumped at a rate of 10 nil/rain into the heat exchanger and 
then passed through an oxygenation chamber (lung) from 
which some passed to the liver and the rest through the 
overflow to the medium reservoir (the perfusate was 
saturated by a moistened mixture of 95/5^ of O^/CO^).
The whole perfusion apparatus was contained in a cabinet 
and controlled at normal body temperature, the air in the 
cabinet being circulated by a fan (Pl^e 6-g). The pathway 
of the perfusion medium was siliconized before the start 
of the experiment (Dacie I9 6 8 ). Polythene tubing was 
used throughout.
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Plate (6-1)
LIVER PERFUSION APPARATUS
Og/COg
R; reservoir, M: magnetic stirrer, P: peristaltic pump, 
H.E: heat exchanger, W. water bath, Lg; artificial lung, 
H: humidifier, C.H; constant head device, t: tap,
PpS: pre-perfusion system , L: liver, F.M ; flow meter, 
V: bile collecting vial, H; heating bars, Tp[: thermostatic 
control device, F: electric fan, A and B: perfusate 
sampling parts.
l4o
Plate (6-2 )
I
\ i
l4i
Perfusion medium» Blood was obtained from a female goat 
( 1 5 0 ml) and pooled in a siliconized Erlenmeyer flask 
containing 2000 units heparin. Red blood cells were 
separated from plasma by centrifugation and these were 
then washed 3 times with isotonic saline. A solution 
was made of medium I9 9 (lOO ml) containing 2,5g 
bovine serum albumin, 5OO units heparin and 7*5 mg 
gentamycin. Washed caprin erthrocytes were mixed with 
6 5 ml of above solution.
Operative procedure. The method has been described previously 
(Miller 1973)• The common bile duct was ligated near to 
the liver and cannulated wi tih fine polythene tubing (pp 2 5 )• 
After cannulation ofthe hepatic portal vein, the infusion of 
a buffer/medium 1 9 9 containing bovine serum albumin and 
gentamycin (35 ml) was started. The liver was dissected 
free and mounted in a plate, transferred to the cabinet 
on the petri dish, then connected to the recirculation 
perfusion medium (diluted red blood cell in medium 1 9 9  
containing bovine serum albumin and gentamycin)• The bile 
duct cannula was led into a test tube (Plate 6 -3 )• The 
perfusion system was checked. Thereafter 4 |iCi of (^^C) 
glucose 6-phosphate was added to the reservoir. The 
collection of 0.2 ml samples by syringing from the taps 
was started after 2 minutes. This was accomplished by the 
simultaneous opening of the taps (one placed above and one 
below the liver). This was carried out at different time 
intervals. Also the bile was collected every 3 0 minutes.
The samples of perfusion medium were centrifuged to 
sediment red blood cells, and 5 0 /iI. from the top layers mixed 
with water (0.5 ml) and scdutillation fluid ( 18 ml) containing
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Plate (6-3)
W
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toluene (2 parts) synperonic N X P (l part) and
2,3 diphenyloxazole f 0,55%) was added in vials.
The vials were placed in the liquid scintillation counter 
K.B. (1210 ultrabeta) for determination of C.
Bile samples were prepared for liquid scintillation 
counting by the same procedure used for the top layers 
of perfusion medium.
Radioactivity was determined in terms of riCi/ml 
(Table 6-4 and 6-5),
l44
Time of 
perfusion 
(min.)
2
5
10
15
30
45
60
90
120
180
240
300
3 6 0
420
Plasma radio­
activity pre- 
hepatic 
(nCi/ml)
24.6
26.9
28.2
25.6
2 5 . 9
26.1
2 5 . 9
2 5 . 2
2 5 . 2
2 3 . 8
23.8
22.6 
26.7
25.2
Plasma radio­
activity, post- 
hepatic 
(nCi/ral)
2 3 . 9
2 7 , 4
28.6
25.6
26.2
24.9
25.1
24.3
24.0
25.1
24.1
2i:4
25.0
22.1
Table (6-4) Uptake of D-(U-^^C) glucose 6-phosphate 
by the liver.
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Time of Bile
perfusion Radioactivity
(min.) (nCi/ml)
30 6.7
60 11.9
90 13.5
120 1 7 . 5
1 5 0 18.6
180 28.2
210 25.5
240 22.2
2 7 0 24.0
300 21.4
Table (6-5 ) Biliary excretion of radioactivity after 
perfusion of an isolated rat liver with D-(U-^^C) 
glucose 6-phosphate,
was trapped in a solution of ethanolamine in ethoxyethanoi (20%
2 IV ■.
2 X 250 ml). At the end of the experiment aliquots of the trapping 
agent were analysed for radioactivity by liquid scintillation spectro­
metry, but were found to contain negligible amounts of
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Results
l4Incubation of hepatocytes with C- labelled
glucose 6-phosphate leads to a higher concentration
of radioactivity in the isolated hepatocytes than in
the medium* The activity was increased by a higher
percentage viability of hepatocytes, but the presence
of NADP, biphenyl or ethylmorphine had only a minor
stimulatory effect (Table 6-l). Incubation of
14
hepatocytes with C-NADP similarly leads to a specific 
uptake of the coenzymes by these cells, with 5 to 7 times 
the specific radioactivity of the incubation medium.
The simultaneous addition of glucose 6-phosphate, or 
the substrates biphenyl or ethylmorphine, makes little 
difference to the uptalte, ^^C-giucose is taken up by 
the hepatocytes, to about the same extent as glucose 
6-phosphate, The simultaneous addition of NADP, glucose 
6-phosphate, or substrates make little difference to 
the rate of uptake. The slight decrease in specific 
radioactivity of the perfusate, from 28 to 23 nCi/ral, 
as perfusion of the liver proceeds, is matched by steady 
increase in the specific radioactivity of the bile 
(6.7 to 28 nCi/ml from 3 0 to 180 min of perfusion).
Conclusions
1. Confirming the previous experiments we find 
that ^^C-glucose 6-phosphate and ^^C-NADP are taken up 
by the hepatocytes.
2. This is unlikely to be due to the cells being 
non-viable because with 100^ viable cells the uptake of
l47
glucose 6-phosphate was more than twice that of a 
preparation with 8 3^ of the cells viable.
3 . Furthermore, perfusion of an isolated liver
with ^^C-glucose 6-phosphate lead to uptake of the
radioactivity with excretion in the bile (probably in
the form of glucuronide conjugate). If the cell can 
l4utilize the C-glucose 6-phosphate it is likely to 
be viable•
4. Although the radiochemical purities of the 
l4 l4C-glucose 6-phosphate and C-NADP were not determined
it is unlikely that the uptake of radioactivity was due
only to impurities or hydrolysis of these compounds
since the ratios of ^^C in hepatocytes/^^C in medium were 
14for C glucose 6-phosphate, 2.1 and'7,2 for 8 3 and 100^
l4
viability; for C-NADP were 5*3 and 6.0 for 80 and 86^
14viability; whereas for C-glucose the ratio was only 2.4. 
The uptakes of ^^C-glucose 6-phosphate and ^^C-NADP would
l4therefore seem to be more rapid than for C-glucose.
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CHAPTER VII
GENERAL DISCUSSION AND FINAL CONCLUSION
General Discussion
It is not possible to state that any one of the 
models used in drug metabolism is better than the others.
Much of the new literature published although clarifying 
one aspect confuses the field as a whole. It is possible 
only to draw attention to advantages and disadvantages 
of each technique.
The use of intact animals as experimental models in 
xenobiotic studies are ideal if all that is required is a 
simple answer such as the nature of the end product.
However, it is rare for such experiments to yield more 
fundamental information, such as the location of specific 
receptor-sites, pathways of detoxification, the factors 
affecting the pathway of metabolism, or the mechanism by 
which toxic damage occurs. It is virtually impossible in 
whole animal experiments to investigate in detail the various 
biochemical processes and to assess the factors regulating 
them. Nor is it possible to regulate the conditions 
perfectly.
In vitro studies make it possible not only to study 
metabolism in particular organs, but also to control and 
monitor the conditions carefully. Once biochemical pathways 
have been established as being similar in different organisms 
it is possible to use other sources of material as an 
alternative to the animal body, e.g. Pseudomonas putida
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which has the most important biocatalyst "cytochrome P-450" 
and this has been purified by Gunsalus and his collaborators 
(1 9 7 2 ). This haemoprotein has also been found in yeast 
(Wiseman, Lim & McCloud, 1975) (Fig. 7-l)•
The liver consist of different cells (Table 7-l)*
Tissue
Parenchyma 
Re ticulo-Endotheliai
Bile duct
Connective tissue
Blood
Blood vessel
Walls
Cell classes 
Hepatocytes
Littoral (Kuppfer cells 
and indifferentiated 
living cells)
Bile duct 
epithelium
Fibroblasts
Macrophages
Erythrocytes 
Leucocytes 
Lymphocytes 
Monocytes 
Plasma cells
Fibroblasts 
Pavement epithelium
Site
intra-lobular
inter- and 
intra-lobular
inter- and 
intra-lobular
Lobular
The percentage distribution in the rat being as follows 
(Table 7-2 )
Parenchyna 60^
Littoral 33%
Bile duct 2%
Connective tissue 2%
Blood vessel walls 2%
(Daonst 1958; Gates ejt aT I9 6 1 )
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Fig (7-I) - U.V, Spectra of cytochrome P-420 and P-450
3
from isolated rat hepatocytes and yeast cells.
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The figure shows the similarity in spectra obtained from 
isolated rat hepatocytes with those obtained from yeast 
cells (Gondal G, , Biochemistry Department, University of 
surrey) 1 5 1
Thus with this in mind, the different constituents 
have differing metabolic capabilities. For example,
Kuppfer cells contribute to dealkylation of ethylmorphine 
in a minor way (Hupka & Karbar 1973)* Liver slices 
contain all these constituents and therefore give the 
more detailed picture of xenobiotic metabolism. In this 
technique the thinnest slices give the best results 
(the physiological condition). However two possibilities 
may occur when drug(s) are in contact with the tissue.
1 . By their very nature, tissue slices contain 
all of the constituents of the tissue but the 
peripheral cells are damaged, thus the rate of 
drug metabolism varies from the outside to the 
inside of the slice.
2. The time required for penetration of xenobiotic 
molecules or macromolecules into the slices to 
the receptor-site and the release of products for 
estimation should be considered (it is not possible 
to make slices less than 0 . 5  mm thick).
The slices are not thin enough to allow oxygen (1 atm) 
to penetrate to all of the cells and the tissues may suffer 
from anoxia (Figueroa e_t al I9 6 6 ). Also, Warburg (1 9 2 8 ) 
mentioned that the maximal thickness a tissue slice may 
attain, without limitation of the respiration of most 
interior cells through inadequate supply of oxygen, may be 
calculated by the following equation:
ÏÏ
Where is the oxygen concentration (in atmosphere) 
outside the slices, D the diffusion constant in the tissue
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and A the rate of oxygen uptake expressed in ml/min/ml of 
tissue, d represents the thickness of the tissue slice 
( cm) •
So, to create ideal conditions is very difficult.
Oxygen at high pressure may have harmful effects on the 
metabolism of mammalian tissue vitro or may affect the 
activity of the enzymes (Stadie, Riggs & Hougaard, 19^5)*
Usually, an organ or a piece of an organ consist of 
several kinds of cellular and noncellular components and 
it is important to determine which of these components 
contain which biocatalyst(s) and perform which metabolic 
reaction(s). For example, finding that the acétylation 
of sulphanilaraide occurs in reticular cells rather than in 
parenchymal cells of liver (Gavier I9 6 5 ), and the comparative 
uptake of sulphobromophthalein by Kuppfer and parenchymal 
cells (stege. Loose & DiLuzio 1975). Parenchymal cells 
have been assumed to be largely responsible for many of 
the organ-specific functions of liver (Doljanski I9 6 0 ) 
e.g. xenobiotic metabolism normally occurs in the 
parenchymal cells of the liver, which form the majority 
of hepatic cells (Table 7-2).
Isolated Hepatocytes
The technique of isolated cells has obvious advantages 
over préparation of liver slices., in that the cells are 
constantly bathed in medium and therefore the diffusion 
barriers to xenobiotics and oxygen are minimized. Also, 
it is a simple preparation to handle and subcellular 
relationships are maintained intact. There are many kinds
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of techniques available for the isolation of hepatocytes, 
but it has been shown that most of these methods are 
unsatisfactory (the use of an enzyme, non-physiological 
chelating agent* or mechanical procedure for separation 
of the cells etc.). In this situation, it is imperative 
to decide in advance which parameter(s) of the whole 
organ must be retained during the procedures of 
separation and to choose the best method which retain 
all of the appropriate characters. This technique which 
is still imperfect has been developed recently (see 
Chapter l). Some of the primary precautions to be taken 
in order to get a high yield of viable cells, are as 
follows :
During anaesthesia the animal should not be excited, 
because of hormonal effects on the cellular enzyme(s).
The anaesthetic should be a minimal dose (50 mg/kg); 
multiple or excessive doses quickly affect the cellular 
enzyme(s). One should be very skilled in operation 
techniques (especially cannulation) because delay in this 
procedure can result in blood coagulation and blockage of 
the capillary veins, (perfusion barrier). During the 
preparation of the isolated hepatocytes it is also 
necessary to treat them gently and to avoid (a) rapid 
pippetting through a narrow hole, (b) stirring too 
quickly with a magnetic stirrer or (c) bubbling oxygen 
through the suspension medium too vigorously. The speed 
of centrifugation is also critical (2 minutes at the 
maximum 200 g in these experiments), (Berry, 1972) 
suggested and (Grunnt, 1972) 10,000g for 3 seconds.
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If* the dye exclusion test is a good method for determination 
of cellular viability, keeping the temperature at 37° after 
separation of the cells results in a gradual decrease in 
viability, whereas use of different buffers during the 
incubation of the cells has little effect upon viability.
Some workers have used collagenase and hyaluronidase 
for isolation of hepatocytes and concluded that the yields 
of viable cells are higher them by using mechanical methods 
(Gallani-Hatcharard & Gray 1971; Lip son, ejb al, 1972;
Muller, e_t a^, 1972). This was a valuable advance until 
other workers drew attention to the disadvantage of 
hyaluronidase, which accompanies collagenase, by causing 
damage to the cells (Wagle & Imgelretsen 1974). Later, 
it was discovered that the amount of.collagenase used 
for the isolation of hepatocytes is critical (Wagle 1975).
In spite of the views of Berry & Werner (1972) different 
amounts of collagenase (25 - 50 mg/lOOml) were used in 
this study.
Calcium is an essential constituent of the so called 
"adhesion factor" which exists between cells (Modjanova and 
Malenkov 1973). Consequently, Caldwell (l970) suggested 
the use of a chelating agent such as EDTA or EGTA, in 
Dulbecco*s calcium free P.B.S. to remove calcium from the 
liver and aid the dispersion of hepatocytes (Seglen 1972). 
However, Mascona, Tramell & Willmer (1 9 6 5 ) and Cuthbert (1 9 7 0 ) 
have reported that calcium ions play a very important role 
in maintaining normal cellular function. Its removal
may therefore have undesirable effects on hepatocyte 
function.
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Once the calcium chelate has been formed, there will 
be in solution, a mixture containing free calcium ions 
and the calcium chelate, which together will produce a 
buffering effect (Caldwell 1970)* This should not be 
too much of a hazard, however, as there is no recirculation 
of this solution through the liver during the procedure. 
Also calcium has to be added to the collagenase buffer 
in order to achieve maximal activity of the enzyme (Seglen 
1 9 7 2 ; Hamard, Lee & Pesch 1973)# It is possible that this 
calcium may be utilised by the cell if necessary.
Cell Viability
One of the most significant points in this technique 
which is still obscure is the question of cell viability. 
What is meant by the term "viable"? What should viable 
cells do? Are there different classes of viability?
Usually preparations were 73 - 93^ viable (trypan blue 
test). Very rarely were viabilities obtained which were 
greater than that.
Various methods have been applied to determine all 
viabilities viz (l) microscopic appearance of cells;
(2 ) oxygeh uptake as a measure of respiratory activity 
(lype & Bhargava 19&3; Ontho I9 6 7 , Howard & Pesch I9 6 8 ; 
Barry & Friend I9 6 9 » Jeykyk & Liberti I9 6 9 , Hammes 
Draismaxmolenaar I9 7 0 ); (3 ) membrane permeability i.e. both 
leakage of contents such as cytoplasmic protein (Jacob 
& Bhargava I9 6 2 ) and glucose 6-phosphate dehydrogenase 
(Hupka & Karlor 1974) and uptake of different solutions 
such as trypan blue (Fry aX 197^). Also, cells
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prepared by incubation of liver with lyzozyme have been 
shown to retain all their nucleotides (Hammes e_t aX 1970)*
It has been reported that the leakage of enzymes may be 
restricted by the presence of corticosteroids (Tokeda 
et al 1 9 6 4 ); it has also been concluded that a major 
permeability barrier restricts the entry and exit through 
the outer liver cell membrane (Hems, Stubb & Krebs I9 6 8 ).
It is suggested that loss of protein does not mean the 
general breakdown of membrane structure because the cell 
has the metabolic capability of synthesising and secreting 
protein, e.g. albumin (Weigand e_t al 1971» Mayo Johnson 
et al 1 9 7 2 ; East e_t al^  1973)» (Wagle & Ingelretson 1975) 
and fibrinogen (Grane & Miller 1974). Also, such cells 
can synthesise glycogen (Seglen 1 9 7 3 ) and regulate 
tryptophan oxygenase in primary rat liver cell suspensions 
by glucocorticoid hormones (Berg, e_t aX, 1972). The 
presence of the above characteristics does not necessarily 
mean that isolated hepatocyte are biochemically viable.
Bickel & Gigon (l97l) reported that the cofactors cannot 
penetrate cell membranes, but this is contrary to present 
results (see Chapter Vl).
One of the most important types of study, using 
hepatocytes as the experimental model, is enzyme induction, 
this may prove the validity of the idea of classes of 
viability.
Isolated liver cells have several other characteristics:-
1, The rate of metabolism of biphenyl in cells 
poisoned with biphenyl (substrate) and the rate of metabolism 
of thiabendazol in non-poisoned cells are similar (cell
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viability was tested using the trypan blue exclusion test), 
see Chapter III),
2, The various classes of viable cells, if they exist, 
(see Chapter III) may metabolise different substrates 
at varying rates. This is shown by the very high S,E,M, 
values obtained not only in the absence of NADPH-regenerating 
systems but also in the presence of NADPH-regenerating 
systems (see Chapter IV), On the other hand, in that 
chapter it was also shown the hepatocytes in non-physio- 
logical conditions (hypotonic buffer) gave similar results 
to viable cells (cell viability again tested with trypan 
blue),
3# The presence of a NADPH-regenerating system, when 
the cells are viable helps conjugation formation rather 
than formation of the free metabolite but the total 
amount of metabolites (free and conjugated) remain more 
or less the same. In any case, the activity of the cell 
decreases with time (see Chapter V),
4. Cells (viable or non-viable) are able to take 
up glucose 6-phosphate and NADP at the same rate as 
glucose (see Chapter Vl),
It is noticeable that the more "pure" a preparation 
is the more susceptible it becomes. For example, the 
isolated perfused liver remain viable for many hours, 
whereas isolated cells die more quickly. None of these 
models (slice, hepatocyte, microsomal preparation perfused 
liver) can be expected to carry out the full array of mixed 
function oxidations characteristic of the liver in vivo,
Enzyme deficiency is only one possible basis for altered
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function. It is also possible that such factors as 
lack of the proper substrate, failure of the cells to 
generate cofactors, or disruption of physiologically 
important intracellular or intercellular relationships 
may play additional roles, (Bissell 1978), The functional 
changes which occur to hepatocytes in culture over the 
course of a few days or in some instances in a matter of 
hours, have been reported by Bissel, Haramaker/<& Meyer 
1973; Tousian 1973; Bonney, 1974), Moreover, such changes 
span a considerable range of hepatic characteristics, 
including lipoprotein secretion (Weinstein & Engelhorn 
1 9 7 4 ) cytochrome P-430 content (Guyelian & Bissell 1974), 
and activity of specific enzymes such as glucokinase and 
aldolase B (Bonney 1974), UDP-glucuronyl transferase 
(Skea & Nemeth I9 8 9 ), or microsomal heme oxygenase 
(Bissell et ^  1974).
Bissell (1 9 7 8 ) reported that studies of culture- 
adaptive phenomena may be expected to yield information 
with regard not only to the correct formation of hepatocyte 
culture but also to normal physiology.
It is suggested that functional changes occur
in the hepatocytes following infusion of the liver with 
an artificial medium through the/ hepatic portal vein 
during the isolation procedure, ' Staryl ^  af (1973) Mas 
observed similar effects in vivo.
Also, microscopic examination is not capable of 
demonstrating viability and membrane integrity. Intact
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cells under the light microscope are readily recognised 
by their roundness and refractibility; they do not take 
up trypan blue (if dye exclusion is a correct method for 
testing (Fig. 2-2), Chapter II). The cells also look 
rather nice under the scanning electron microscope 
(Fig. 2-4, Chapter II)•
Neither is oxygen uptake a good test because it is 
possible that it may require only the mitochondria to 
remain intact for molecular oxygen to be taken up for 
utilisation in the tricarboxylic acid cycle (Oubinsky & 
Cockrell 1 9 7 4 ).
Various metabolic parameters have been measured and 
reported but the whole question of cell integrity and 
viability requires more thorough investigation. That 
isolated cells may take up cofactors has already been 
discussed (Chapter Vl). It is possible that these cells 
are not truely viable, in that they are able to synthesise 
adequately their normal range of proteins, although such 
preparations may still retain some sort of relationship 
between the subcellular organelles.
This being so, the use of such preparations in drug 
metabolism studies could yield valuable information if 
compared with results of microsomal studies, as the 
physiological arrangement of the organelles could enhance 
metabolism by contributing in some way to the electron 
transport system.
The most common method in use for the determination 
of cellular viability is the dye exclusion test, normally
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being used, Suzangar & Dickson (1970) & Dickson (1 9 7 1 ) 
suggested that the viable hepatocytes can take up trypan 
blue into the nucleus but the non-viable ones can be 
stained uniformly. But this cannot be substantiated (see 
Fig, 2-2, Chapter II), Also Wheatley (1972) stated that 
about 3 0^ of hepatocytes are binuclear in adult rats, but 
throughout my project, I have never seen more than 5^
(under the light microscope by addition of trypan blue).
It is concluded that two possibilities may occur, (l) either 
there are not 3 0^ of hepatocytes that are binuclear, or 
the multinuclear cell has not the same permeability as 
the mononuclear cell, (2 ) the binuclear cell is not 
isolated in the same manner as the mononuclear cell and 
when they become separated they always are viable 
(Wheatley 1972).
Many workers using different experimental techniques, 
have reported a similar percentage viability of cells 
( 7 5  - 93^) (Howard ejt al 1973; Berry & Friend I9 6 9 ;
Haung and Ebner I9 6 9 ; lype 1971; Capuzzi, Rothman and 
Margolis I9 7 I; Lentz & Diluzio 1971; Weigland, Muller & 
Chreicher 1971; East, Louis & Hffenberg 1973» lype, Baldwin 
& Glavers 1973; LaBrecque et al 1973 compared the methods 
of Capuzzi et al ( 197l) with that of Howard e_t al ( 1973) 
and concluded that the latter, which employed the perfusion 
technique gave better results than the former (slices). 
However David ejt al ( 1973) raised the general problems of 
how intact cells could be observed as no one has ever seen 
functional intact liver cells within the intact liver.
Inaba ejk aJL ( 1 9 7 3 ) stated that isolated hepatocytes,
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in spite of their obvious advantages, have not been 
widely employed because of poor yields and their short 
viability.
In the case of xenobiotic metabolism, my experiments 
have shown that a few metabolite(s) (metabolic 
intermediates) remain within either the intracellular 
or extracellular space or both. As Williamson (l9?2) 
suggested, the cell membrane is more permeable in the 
isolated cell system than in the perfused liver. So 
metabolite(s) remain only in the extracellular space 
(in liver slices). In using isolated hepatocytes for 
drug metabolism studies short periods of observation are 
preferable to longer periods. It is certainly desirable 
to perform such experiments in addition to those using 
microsomal preparations in in vitro studies of drug 
metabolism.
Although the endoplasmic reticulum has been shown 
to contain many of the enzymes that catalyze the 
metabolism of xenobiotics, many others are known to ooour 
in the cytosol. Furthermore, microsomes may contain other 
subcellular components such as plasma membranes. It 
should therefore not be neglected that by using microsomes 
alone it is not possible to find many metabolic intermediates 
such as glutattïüjoneconjugatej of epoxides and other 
conjugates such as sulphates. The latter could be 
formed in hepatocytes but not as completely as they are 
in the intact organ. Finally it should be mentioned 
that the method which Schneider & Hogeboom (1930) described 
for the separation of the subcellular organelles cannot
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be performed without loss of some of their original 
characters, and loss of enzymic activity* The use of 
hepatocytes in metabolism studies can remedy some of 
these shortcomings and this could be the simplest and 
most complete procedure in the field of xenobiotic 
metabolism*
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Final Conclusions
Biphenyl hydroxylation and ethylmorphine 
N-demethylation in isolated hepatocytes are enhanced 
by addition of NADP and glucose 6-phosphate to the 
incubation medium. It is suggested that these factors 
are taken up actively by the isolated cell. Kanaeva and 
Archakor (l975) have observed similar effects. They 
showed that various hydroxylation activities in isolated 
hepatocytes were increased by the presence of glucose 
6-phosphate - or the isocitrate - NADPH^ regenerating 
systems in the incubation medium, and they also proposed 
an active uptake of glucose 6-phosphate.
Similar results have also been obtained with liver 
slices in which addition of an NADPH^ regenerating system 
caused a slight increase in hydroxylating activity.
These results are in agreement with those of Bickel & 
Gigon (1 9 7 1 ) who suggested that the damaged peripheral 
cells of the slices were responsible for taking up the 
cofactors with the subsequent increase in activity.
These results are of particular interest for as long 
ago as I9 3O; Cori suggested that glucose 6-phosphate 
added to glucose/saline aided recovery for post—surgical 
shock. It was believed that glucose 6-phosphate primed 
the synthesis of ATP in the hepatocyte and so facilitated 
the active uptake of glucose. However, although this 
practice is in wide use in Germany and Italy, it was 
never adopted in the United Kingdom or the U.S.A. This 
was because it was considered that hexose phosphates
164
were not taken up by the liver cell and Chain, e;t al, 
(1 9 5 6 ) was unable to demonstrate any uptake of glucose 
6-phosphate by isolated rat diaphragm.
Hence the present finding that glucose 6-phosphate 
increases the activity of certain hepatic enzymes is of 
considerable importance and it is possible that damage 
to the hepatocyte during preparative procedures results 
in changes of membrane permeability of the hepatocyte.
If similar changes occur as the result of administration 
of anaesthetics or other drugs, or as the consequences of 
post-surgical trauma, it is possible that intravenous 
administration of glucose 6-phosphate may indeed be 
useful in post-surgical treatment. This remains to be 
further investigated. -
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